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THE GENETIC AND ENVIRONMENTAL INFLUENCES ON FEAR, ANXIETY, AND
POSTTRAUMATIC STRESS SHARED WITH BRAIN MORPHOMETRY
By Chelsea K. Sawyers, B.S.
A dissertation submitted in partial fulfillment of the requirements for the degree of
Doctor of Philosophy at Virginia Commonwealth University.
Virginia Commonwealth University, 2018.
Major Director: Michael C. Neale, Ph.D., Professor, Department of Psychiatry
Anxiety disorders (ADs) and stress-related disorders are some of the most common
psychiatric disorders in the United States. Like other c0mplex psychiatric illness, genetics
and neuroimaging research has focused on understanding their underlying neurobiology.
Areas within the fear-network play important roles in threat perception, fear
conditioning/learning, cognitive processing, and modulation of fear responses including
contextual modulation and extinction and have been implicated in ADs as well as stress
disorders such as posttraumatic stress disorder (PTSD). The primary gap in the current
search for underlying biological mechanisms is in whether biomarkers associated with
disorders share genetic influences with the disorders they index. Therefore, the aims of
this dissertation are: 1) to examine the shared etiology of PTSD and threat-related brain
regions while accounting for trauma using a large sample of male twins who served in the

military during the Vietnam War; 2) to elucidate the shared and specific risk factors
(genetic, familial environment and unique environment) and their roles amongst fear and
anxiety domains in children; and 3) to examine whether brain regions previously
implicated in fear processing and anxiety are significantly associated with a genetic factor
score indexing fear and anxiety measures in a child sample. Using biometrical twin
modeling this dissertation produced several novel findings regarding etiology of PTSD,
threat-related domains and associated brain morphometry. Analyses investigating brain
morphometric differences as potential endophenotypes for PTSD provided preliminary
evidence that their phenotypic association is largely accounted for by environmental
influences, specifically trauma exposure. However, sample size-induced model instability
limits the ability to make definitive conclusions. Examining domains of fear and anxiety
in children suggested a substantial genetic overlap between the two.

Finally, the

incorporation of a genetic factor score derived from the results of the biometrical
modeling of fear and anxiety provided preliminary evidence for a genetic relationship
between fear/anxiety and brain regions of interest. Although these results should be
interpreted within the context of important limitations, they provide clear evidence that
additional research into the genetic relationship between brain regions and disorders with
larger sample sizes is justified.

Chapter 1: Global Introduction
Anxiety disorders (ADs) such as panic, generalized anxiety, social phobia, and
specific phobias are some of the most common psychiatric disorders in the United States.
Although now in a separate section in the 5th edition of the Diagnostic and Statistical
Manual1 (DSM-5), posttraumatic stress disorder (PTSD) was once considered part of the
AD2 group and retains a high degree of comorbidity with the ADs.

Psychiatric

neuroimaging research has focused on understanding the underlying neurobiology of
these disorders.
Before we can begin to examine the underlying biology, it is important to first
describe what exactly is being examined. There are two main phenotypic paradigms
researchers use when studying psychopathology: diagnoses from the DSM and other
diagnostic classification systems, and systematic domains and constructs from the
National Institute of Mental Health (NIMH) Research Domain Criteria (RDoC) initiative.
Until recently DSM diagnoses, and to a lesser extent symptom counts, were the primary
foci of inquiry. However, the NIMH has emphasized the need to broaden research of
mental health outcomes beyond diagnostic boundaries via creation of the RDoC initiative.
RDoC was created to implement Strategy 1.4 of the 2008 NIMH Strategic Plan: “Develop
new ways of classifying disorders based on dimensions of observable behaviors and brain
functions” and assumes that mental illness is a disorder of brain circuits, with
biosignatures detectable via genetics and clinical neuroscience
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research which will ultimately be used to augment symptom assessment for diagnosis and
treatment planning.3 This shift beyond diagnoses may also help researchers find
underlying biological mechanisms that are ultimately shared across diagnoses and in part
account for the high comorbidity seen between certain disorder groups. The search for
underlying biological mechanisms is heavily focused on identifying whether a biomarker
meets the criteria for an endophenotype of the disorder.

To be considered an

endophenotype a biomarker must: 1) associate with the disorder in the population; 2) be
heritable; 3) be state-independent (i.e., is present whether disorder is active or not); 4)
co-segregate with the illness within families; and 5) also present in unaffected family
members of affected individuals at a rate higher than that of the general population.4
Endophenotypes are thought to form part of a neurobiological bridge between
phenotypes

and

genotypes.

The

focus

on

endophenotypes

and

biological

mechanisms/markers shared across diagnoses may be especially effective for
neuroanatomic magnetic resonance imaging (MRI) as the functional MRI (fMRI) studies
are task specific and as such are not as amenable to comparisons across disorders
compared to structural MRI, which does not require task activation. Currently, research
involving fMRI uses case-control group comparisons to examine differences in taskelicited activation of specific regions. Task-based analyses are designed to elicit activation
in either a specific structure or a specific network of structures5 (e.g. the fear network)
and as such, it becomes difficult to disentangle whether differences between studies were
due to the different tasks used or represent distinct findings. To a more minor point, the
possible variations in definitions of a ‘case’ (e.g., only generalized anxiety patients (GAD),
GAD plus other anxiety disorders such as social anxiety, or panic, or GAD with or without
major depression comorbidity) can further complicate aggregations of study findings.
2

Hallmarks of ADs in general include excessive fear, avoidance, and worry in
response to specific stimuli and absent of any imminent danger1. ADs are some of the
most common psychiatric disorders within the community6, and neuroimaging research
has focused on understanding their underlying neurobiology. Since excessive fear is a
core element of ADs symptomatology, research into their neurobiology has largely
derived from the study of fear circuits in animal models. Key components of this fear
circuitry include the amygdala, hippocampus, hypothalamus, insular cortex, anterior
cingulate cortex (ACC) and areas of the prefrontal cortex (PFC) which can go by many
labels including the ventromedial PFC, and the medial or lateral orbitofrontal cortex
(mOFC; lOFC).

These areas play important roles in threat perception, fear

conditioning/learning7,8, cognitive processing, and modulation of fear responses
including contextual modulation9 and, in some circumstances, extinction10. The theory
is that by understanding the mechanisms related to the symptoms more effective
treatments can be developed or refined. Figure 1.1 illustrates the divisions of the OFC and
ACC while figure 1.2 shows the structure of the hippocampus and amygdala.

a

b

Figure 1.1 Divisions of the left orbitofrontal and anterior cingulate cortices
Panel a shows a sagittal cross section and b shows an inferior view of the left
hemisphere. Medial orbitofrontal cortex (OFC) is illustrated in dark blue, lateral
OFC in light blue. Caudal anterior cingulate cortex (ACC) is in light green and
rostral ACC is in dark green.
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a

b

c

Figure 1.2 Bilateral Structures of the Hippocampus and Amygdala
Panel a shows a sagittal view of the hippocampus (light blue) and amygdala (yellow), b
shows a coronal view and c shows a 3-dimensional bilateral reconstruction of the structures
with a sagittal cut of the left hemisphere to provide relative spatial context.

The basic areas of the fear-related neurocircuitry are a useful place to begin
examining anxiety-related neurocircuitry. It should be noted that the specific roles of
many brain regions have not been unequivocally established. Generally speaking, studies
examining these areas have found increased amygdala activation in response to disorderrelevant stimuli in posttraumatic stress11,12, social phobia13–16, and specific phobias17,18.
There is some evidence to suggest reduced hippocampal volumes may be unique to PTSD
in comparison to ADs but is not unique across all psychiatric disorders. Additionally,
positron emission tomography and fMRI studies of PTSD have found a decrease in19,20,
or failure to activate21 the PFC (including ACC) when presented with trauma related
stimuli19,20, and fear extinction21 tasks. Whereas disorder-relevant stimuli have elicited
hyperactivation of these areas in GAD22, and phobia patients.23 Evidence also suggests
that morphometric differences in these PFC areas are associated with these disorders to
varying degrees. Thus far it is not clear whether these functional and morphometric
differences are the cause or the effect of specific disorders, and further research is needed
to untangle them. Given the accumulation of studies and meta-analyses that associate
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PTSD and ADs with morphometric differences in the brain, it is a logical next step to
investigate potential shared etiology between PTSD/ADs and regions of interest (ROIs)
with the goal of identifying whether ROI morphometries meet the criteria for
endophenotypes of PTSD/ADs.
The data available for this dissertation did not have all three phenotypes of interest
(PTSD, fear, and anxiety) available in one sample. Therefore, to capitalize on available
data, lines of inquiry were split between an adult and child sample. ADs are some of the
most common psychiatric disorders within a community whether examining adult or
child prevalence rates, whereas PTSD is less so in adults and children. Additionally, many
ADs begin in childhood. Therefore, this dissertation will focus on PTSD and fear-network
ROIs within an adult sample and will use a child sample to investigate fear and anxiety as
they relate to fear-network ROIs.

Posttraumatic Stress Disorder and Trauma Exposure
PTSD Prevalence and Etiology
Exposure to accidental and interpersonal forms of trauma, such as a car accident
or physical and emotional abuse, respectively, is associated with many negative
consequences including the possible development of PTSD.24

PTSD involves the

persistent reexperiencing of a traumatic event through nightmares, intrusive memories,
or flashbacks, persistent negative thoughts and emotions, and hyperarousal or excess
reactivity after the event. According to the World Mental Health Survey Consortium, the
United States has one of the highest rates of trauma exposure with 82% of participants
from the United States endorsing at least one traumatic event.25 Whereas, most European
countries had endorsement rates below 80%, and Asian countries generally had even
5

lower rates (52% endorsement in China, and 60% endorsement in Japan).

While

estimates of the prevalence of trauma in the United States range from 60-90%26, the
lifetime prevalence of PTSD is 10-12% in women and 5-6% in men with approximately 8%
of the total United States population developing PTSD at some point in their lifetime.27
Therefore, it is possible to conceptualize a PTSD diagnosis as an inability to recover from
the effects of trauma. Subsequently, understanding the role of trauma exposure on the
biological systems involved in the development of PTSD may help to improve prevention
and treatment for individuals at risk for PTSD after exposure to trauma.
PTSD is a moderately heritable (30-72%) condition across a range of trauma
types28–31, and several biological systems may be involved in its development. PTSD is
highly comorbid with anxiety disorders and major depressive disorder.31–34 The high
comorbidity may be explained, in part, by substantially overlapping genetic influences as
is the case with PTSD and MDD in women31 and men34.

Trauma Types
Trauma exposure can be categorized into a few main types including:
interpersonal, accidental, military, and childhood. A major distinction in trauma types as
identified via principal components analysis is between assaultive (or interpersonal) and
non-assaultive trauma.30 In the context of civilian trauma, assaultive trauma includes
experiences such as being robbed, held captive, sexual assault, and other life threatening
experiences.30,35

Whereas non-assaultive trauma encompasses experiences such as

sudden family death, car accident, fire, and natural disasters (i.e. tornado, flood,
earthquake etc.) and are generally thought to be more random in nature.30,35 In general,
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individuals exposed to assaultive traumatic events are at a higher risk to develop PTSD
compared to events without an interpersonal component.35–38
Men and women experience these types of trauma at differing rates with men
generally experiencing overall higher rates of trauma exposure with 61% of men
compared to 51% of women reporting at least one traumatic experience.27 Women are
more likely to be exposed to interpersonal traumas25,27,35,39, specifically sexual assaults,
and men are more likely to experience accidents, interpersonal violence, and combatbased traumas.25,27,39 Additionally, while men experience more events, women were at a
higher risk for PTSD when controlling for trauma type in a community based sample35 as
well as in a meta-analysis.39
Trauma due to combat exposure during military service is experienced in roughly
equal proportions between men and women. Of those who served during the Vietnam era
30% served in southeast Asia, and 15% of vets are thought to have been directly involved
in combat40 with an additional 14% exposed to combat hazards while serving.41 Within
samples of more recent veterans of Operation Enduring Freedom (OEF), Operation Iraqi
Freedom (OIF), and Operation New Dawn (OND), the rate of combat exposure is
substantially higher, with 95%42 of returning veterans reporting exposure to at least one
combat trauma event.
Trauma exposure that occurs during childhood is thought to have an especially
strong influence on the development of psychopathology within child- and adulthood to
a greater extent than experiencing traumatic events as an adult. This is supported by
distinct epigenetic43,44 and neurobiological45 alterations that are associated with
childhood but not adult trauma. Various studies have reported the prevalence of exposure
to different trauma types during these developmentally sensitive time periods. According
7

to the Nation Survey of Children’s Exposure to Violence depending on how trauma is
defined and the reporter used, 8-12% of American youths (0 - 17 years old) have
experienced at least one sexual assault, 9-19% have experienced physical abuse by a
caregiver, and 38-70% have been witness to serious violence within the community.46
Additionally, 20% of all youths had experienced more than one type of trauma. Studies
have shown that higher levels of trauma are linked to more severe forms of distress in
adolescents.47,48
When examining the etiology of trauma types, it was found that assaultive trauma,
being related to human behavior, is influenced by genetic factors, while non-assaultive
traumas were not. Heritability of assaultive trauma varies greatly within this broad
category. ‘High-risk’ traumas had a heritability estimate of 60%31, combat exposure
within a male sample estimated heritability at 35-54%49 with the highest heritability
estimates being associated with receiving combat decoration, and a heritability estimate
of 20% for a general measure of assaultive trauma.30 It has been theorized that these
genetic influences may be working through differences in heritable traits such as
personality50–52. For example, personality may influence an individual’s choices resulting
in selecting into environments that ultimately lead to an increase in risk of exposure to a
traumatic event, such as after volunteering for military service. Previous studies have
found various personality traits to be associated with increased likelihood for trauma
exposure, such as neuroticism53, psychoticism51 and conduct disorder51,54 (which could
be an early indicator of antisocial personality traits). These are examples of geneenvironment correlations and have implications for research examining genetic
influences on behaviors and are discussed in more detail later.
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The heritability of exposure to various traumatic experiences highlights the role of
complex interactions between potential risk factors, and the trauma exposure/situational
stressors that engenders PTSD development.

Premorbid risk factors, or diatheses,

represent an individual’s predisposition towards development of PTSD and/or other
psychopathology and represent things such as genetic vulnerability, social support and
previous trauma exposure. Under the diathesis-stress model as diatheses accumulate the
severity threshold needed to instigate the development of PTSD decreases.55 The tipping
point for a given individual varies depending on the interaction between the level of
stress/trauma experienced and number of risk factors present prior to the stressor.
Therefore, those who are most liable for PTSD development have a greater accumulation
of diatheses, to the point where they would not require a very severe stressor to reach the
PTSD development tipping point. However, this also means that a person with a higher
level of risk factors would not develop PTSD until they experience a sufficiently severe
stressor.
Within this diathesis-stress model the interactions between environmental and
biological risk factors and the catalytic exposure to stress are complex in nature (e.g. the
previous example of personality and potentially selecting into environments with greater
potential for exposure to traumatic experiences). Research into the stressor/trauma
exposure aspect of this model found that repeated or prolonged exposures to traumatic
experiences greatly increases the likelihood of PTSD development. Broadly, it is thought
that a cumulative exposure to trauma increases not only risk for development of
psychopathology56,57 but also symptom severity58 in a dose-dependent manner. Within
the context of military service, a strong dose-response relation between severity of combat
exposure and PTSD symptoms has been observed in both Vietnam and OEF/OIF veteran
9

samples.54,59–63 This dose-response relationship between trauma and PTSD outcomes
could potentially be acting via several biological pathways associated with responses to
stress including via brain circuits responsible for fear learning.

PTSD and Brain Regions of Interest
Current neurobiological models of PTSD implicate the amygdala, hippocampus,
anterior cingulate cortex (rACC) and ventromedial prefrontal cortex (vmPFC) as regions
of interest (ROIs).64,65 The amygdala is hypothesized to be hyper-responsive in PTSD
potentially explaining the hyperarousal, amplified fear responses, and traumatic
reexperiencing. Alternatively, the vmPFC and rostral anterior cingulate cortex (rACC) are
hypo-active, suggesting that they do not properly inhibit amygdala activation.65–67 It is
not currently understood which of these areas is responsible for the overall disorderbased fear response outcomes, but it is possible for both situations (underactive vmPFC
and ACC, and overactive amygdala) to lead to deficits in fear extinction, emotion
regulation, and contextual processing.68 Changes to hippocampal function are thought to
contribute to the deficits in contextual processing in addition to the changes commonly
observed in memory and neuroendocrine regulation. Additionally, the insula appears to
be hyper-responsive in PTSD and other anxiety disorders and is thought to mediate
susceptibility to anxiety.69,70
Most recent psychiatric neuroimaging research has focused on fMRI compared to
structural MRI. The limited structural literature appears to be split regarding reduction
in hippocampal volume in PTSD, with several supporting reduced volumes71–87 and others
not.88–94 Both camps appear to have support regardless of population examined, type of
trauma exposure, or measure of PTSD (symptom counts or diagnoses), but apart from the
10

meta-analyses the studies have small sample sizes. There have been a few studies on
amygdala morphology in PTSD.

Two meta-analyses reported reduced amygdala

volumes,84,95 but several other studies with smaller sample sizes found no significant
differences between cases and controls.74,83,88,92,96 Reduction in ACC volumes appears to
have more consistent support across different studies67,97,98 and meta-analyses78,79,84,95,99,
with one monozygotic discordant twin design study suggesting the reduction in grey
matter density in the ACC is an acquired disorder indicator (e.g. a stress-induced
reduction) rather than a pre-existing risk factor.67 This is further supported by another
study that showed that, while PTSD and ACC volume were associated with measures of
threat sensitivity and threat response, they also significantly interacted to predict both
outcomes. This suggests that ACC volume may play a moderating role regarding both
threat sensitivity and threat response through impaired habituation in trauma exposed
individuals. Furthermore, morphometric studies have also reported reduced grey matter
density in the insular cortex.67,78,95,97,100 Recently, one study found that a reduction in
cortical thickness of the prefrontal cortex was associated with PTSD symptom load which
remained significant after controlling for potential confounds including medication
status101, supporting the findings of meta-analyses based on PTSD diagnoses.95,99
Although more limited in scope, these morphometric-based analyses implicate similar
regions as fMRI studies and overall show that in some capacity the ACC, prefrontal cortex,
amygdala, insula, and potentially the hippocampus are associated with PTSD. Further
research is now needed to determine if these differences in neuroanatomy represent true
endophenotypes.

11

Resilience to Trauma Exposure and Brain Regions of Interest
When investigating the association between PTSD and ROIs it can be difficult to
distinguish what constitutes a potential risk factor present prior to a traumatic event or
PTSD and what brain morphology differences are due to effects of trauma exposure
and/or PTSD disease processes. One way to untangle this is to incorporate participants
exposed to trauma who did not develop PTSD or other psychopathology into analyses. In
addition to examining PTSD compared to experience-matched controls, it is also possible
to compare the trauma-exposed controls to healthy controls to identify potential
protective factors.
One study found greater cortical thickness in the right temporal cortex in a group
who experienced a single traumatic event (Tsunami) compared to healthy controls.102 A
twin study by Gilbertson et al.82 compared monozygotic twins discordant for service in
the Vietnam War and found smaller hippocampi of both the deployed twin and the one
who did not serve predicted the PTSD symptom load of the deployed twin. These results
suggest smaller hippocampal volume is a risk factor for PTSD rather than an effect of
PTSD-related neuroprocesses. However, their findings are contradicted by two metaanalyses78,84 that found bilateral reduction in hippocampal volume in trauma-exposed
controls versus healthy controls, with one study showing even further reduction in
hippocampal volume in the PTSD group versus the trauma-exposed controls, suggesting
that trauma exposure and development of PTSD is responsible for the reduction in
hippocampal volume.84 It should be noted that reduced hippocampal volume is found in
major

depression,

bipolar

disorder103,

schizophrenia104

and

chronic

hypercortisolemia105,106, which is related to chronic stress. Given these results, reduction
in hippocampal volume may be a generalized marker for mental health disorders rather
12

than a disorder-specific indicator. Another PTSD-focused meta-analysis showed reduced
amygdala volume in trauma-exposed controls compared to healthy controls.79 A rather
large Australian study with 265 participants focused on early trauma exposure rather than
PTSD found those with 2 or more adverse childhood events had smaller ACC and caudate
nuclei volumes compared to those with no adverse events and may implicate the influence
of early trauma exposure on the developing brain.107
In summary, most PTSD MRI studies found morphological differences in the
amygdala, hippocampus, PFC and ACC and these regions have been observed in trauma
survivors without PTSD as well as in individuals who experienced adverse childhood
experiences without later psychopathology. One hypothesis is that these ROI might be
associated

with

risk-resilience

factors

rather

than

occurring

secondary

to

neuropathological processes associated with PTSD.

Fears and Phobias
Prevalence and Etiology
Fear represents the emotional-behavioral response to the perception of immediate
danger, leading one to avoid the threat for discernible survival value.108 Various phobic
fears are common throughout adulthood, with a lifetime prevalence of 7-12%6, and it is
consistently found that girls report more fears than boys during childhood and
adolescence with reliable patterns of waxing and waning in response to developmental
changes.109–112
For researching fears, self-report surveys are a quick, convenient, and inexpensive
way to assess a wide range of fears and provide researchers and clinicians with a wealth
of information. Although there are many fear survey instruments available, the mostly
13

widely used are revisions of Scherer and Nakamura’s Fear Survey for Children.113–116 The
Fear Survey Schedule for Children-Revised (FSSC-R) is a commonly used self-report
measure for measuring fears and fearfulness in children and adolescents.114,117,118 Five
subscales have been consistently found: ‘fear of failure and criticism’, ‘fear of the
unknown’, ‘fear of small animals’, ‘fear of danger and death’, and ‘medical fears’, but they
are mutually correlated supporting the use of the total score as a general fearfulness
index.117 Overall, general fearfulness as defined by the total score of the FSSC-R has been
found to be moderately heritable (0.29), with heritability of specific subscales ranging
from 0.46-0.12.119
Twin studies conducted by our group have found phobias in adults to be
moderately heritable (30-40%) with phobia subtypes having overlapping genetic and
environmental influences as well as subtype-specific factors.120–122 These overlapping
influences help explain the high comorbidity amongst fears and phobias.123 To our
knowledge, no genetic studies of phobic diagnoses have been conducted in children.
However, individual fear symptoms in children have been reported as moderately
heritable with modest familial environmental influences and a greater role for unique
environment.124–126 There has been limited genetic research on the comorbidity structure
of fear symptoms in children, with one twin study reporting a shared latent genetic factor
that influenced all fear symptom clusters in addition to fear-specific factors.124 This
overlap in genetic influence found in child and adult twin studies could be indexing
possible shared biological underpinnings, and this dissertation aims to further
understand their potential brain structure endophenotypes.
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Fears, Phobias and Brain Regions of Interest
Many neurobiological models of phobias and their symptom counts (‘fears’) focus
on mechanisms of fear conditioning and fear extinction and as such primarily implicate
the amygdala and vmPFC. This approach is likely not the complete picture given that 1)
many individuals with phobias do not report a conditioning event, and 2) only a small
number of common stimuli or situations are the focus of phobias.127 Despite these known
shortcomings, fear conditioning and extinction models have provided useful insights into
the roles of the amygdala, vmPFC, and insula in phobias. Within fear conditioning
paradigms an increase in insular cortex128,129, amygdala128,129, and hippocampal activation
are commonly reported, with mixed findings for rACC18,23,129–131 activation changes.
Several morphological differences between cases and controls have been associated with
specific phobias including increased rACC cortical thickness132,133, bilateral increase in
insular cortical thickness132,133, and increased grey matter volume in the left orbitofrontal
cortex132 (lOFC), an area within the vmPFC, and reduced hippocampal134,135 and
amygdalar134,135 volumes. The amygdala, insula, and OFC appear to be hyper-responsive
when presented with phobia-related stimuli with a possible corresponding increase in
size. These differences in morphometric measures tend to disappear in scans following
successful treatment providing additional evidence of their involvement with phobic
neuroprocesses.17,18,136

Anxiety
Prevalence and Etiology
Anxiety disorders (ADs) often have a basis in normal anxious concerns; however,
the degree of anxiety and associated symptoms becomes excessive, uncontrollable, and
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impairing to an individual’s life. The AD group is the most prevalent class of psychiatric
disorders in US adults with a lifetime prevalence of 28.8%.6 Community prevalence rates
of any current AD in children range between 3 and 9.5%137–139 and the cumulative
prevalence reaches as high as 31% in adolescence.140 Similar to fears, girls are found to
have higher rates of ADs throughout both childhood and adulthood.137,141
As with fears, an efficient way for researchers to assess common anxiety disorders
is through self-report measures such as the Screen for Child Anxiety Related Emotional
Disorders (SCARED). The SCARED was originally developed to screen for anxiety
disorders within clinical samples142,143 but has also been widely used in community and
research studies.144,145

It assesses five clusters of childhood anxiety symptoms:

panic/somatic (PAN), generalized anxiety (GAD), social anxiety (SOC) and separation
anxiety (SEP) as well as school avoidance. Several twin studies have examined the
heritability of the SCARED subscales and found the subscales to be moderately heritable
(0.53-0.60) with no familial environmental influence.146 Additionally, the covariance
between the SCARED subscales is also almost entirely explained by genetic factors.147
In general, twin studies have demonstrated that ADs are also moderately
heritable.148 Like fears and phobias, ADs are highly comorbid with each other, and adult
twin studies suggest this comorbidity may be due, in part, to genetic risk factors shared
between disorders.149,150 This high rate of comorbidity is also seen in children, where 40%
to 60% of children with one AD are estimated to meet criteria for additional ADs151,152 and
suggests potential shared underlying biological mechanisms.
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Anxiety and Brain Regions of Interest
ADs are a prevalent problem in the community and neuroimaging research could
provide insights that may ultimately be used to help inform development of new
treatments or possibly predict an individual’s response to various treatment types. It is
not surprising that current research into the neurocircuitry of anxiety disorders is closely
linked to fear circuits in animal models. Both fear and anxiety have a basis in threat
response, with fear corresponding to more acute and imminent threats, and anxiety
related to the concern about potential and long-term threats.153
There has been limited research on differences in volumetric measures associated
with anxiety disorders. According to one study with a limited sample size, smaller
bilateral amygdala volumes were found in panic disorder compared to healthy controls.154
However, another study reported larger amygdala volumes in pediatric generalized
anxiety disorder patients compared to healthy controls.155 Within the functional
neuroimaging literature there appears to be a general consensus of exaggerated amygdala
activation to a variety of disorder-specific stimuli across many anxiety disorders such as
panic disorder156,157, social phobia13–16, generalized anxiety.22,158,159

Here again the

volumetric literature is sparse, but some studies and meta-analyses suggest a reduction
in grey matter volumes in the rACC across multiple disorders including panic, social
anxiety, generalized anxiety and specific phobia160–162 and a decrease in cortical thickness
of the ACC and OFC in older generalized anxiety patients.163 Reduction in left medial OFC
(mOFC) thickness or grey matter volume has also been associated with panic disorder in
a few smaller studies.164–166 OFC is often examined in anxiety disorders (primarily panic
and generalized anxiety) due to its reciprocal connections with the amygdala. It should
be noted that a common limitation across several of these anxiety neuroimaging studies
17

is the inclusion of participants taking psychiatric medications, and the analyses were not
corrected for this potential confound.

Research has shown some medications are

associated with changes in volumes of specific structures.167 Despite these limitations it
appears that fear neurocircuitry is involved in some capacity in our current understanding
of the biological mechanisms of ADs.
This dissertation examines the relationship between brain ROI and threat-related
psychopathology in adults (PTSD) and children (anxiety and fears) with the ultimate goal
of beginning to connect dimensional measures of psychopathology to basic biological
components of mental health using genetically informative samples.

Based on the

previous literature presented above, this dissertation will focus on six main regions in
each hemisphere of the brain: hippocampus, amygdala, rACC, cACC, lOFC, and mOFC
(which combined with the lOFC capture a commonly studied area of the PFC). These
areas have been associated with PTSD and/or ADs and have a known involvement with
fear neurocircuitry in animal models. The broad aims of this dissertation will bridge the
current gaps between heritability of psychopathology, heritability of ROIs, and
morphometric changes associated with psychopathology. This will be accomplished by:
1) examining the etiological relationship between PTSD, specific brain regions, and the
role of trauma in that relationship, 2) investigate the shared and specific risk factors
(genetic, familial environment and unique environment) and their roles amongst fear and
anxiety domains in youth, and 3) determine whether genetic factors shared with fear and
anxiety are associated with specific brain regions. These aims and the required analytic
approaches are summarized below.
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The Role of Trauma in the Etiology of PTSD and ROIs
Chapter 2 addresses the first aim of this dissertation by examining the strength of
the etiological relationships between PTSD and ROIs previously implicated via functional
and structural MRI studies. Several areas involved in the processing of threatening
stimuli have been associated with PTSD. PTSD28–31 and ROI morphologies168–170 are both
considered moderately to highly heritable. Given their heritability estimates and known
phenotypic association, it is plausible that PTSD and ROIs have a shared genetic etiology.
Another important consideration in examining this potential etiological
relationship is gene-environment correlation, because it could falsely appear as a gene by
environment interaction.171 Previous studies using the Vietnam Era Twin Registry show
evidence of such gene-environment correlation between PTSD and combat exposure.57-59
Also, given that exposure to adverse childhood experiences is associated with
morphometric differences in areas such as the ACC and hippocampus, areas also
associated with PTSD, it is important to account for trauma exposure when examining
etiological overlap between PTSD and ROIs. Morphological differences may in fact be
risk factors for PTSD development rather than an effect of trauma exposure and PTSD
neuroprocesses.
Accordingly, the aim of chapter 2 is to examine the shared etiology of PTSD and
ROIs while accounting for trauma using a large sample of male twins who served in the
military during the Vietnam War. There are several potential models available to fit (e.g.
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Cholesky, correlated factors, simplex etc.),

rE
rC

and the model ultimately chosen depends on
the underlying theory being tested. Since

rA

E1
C1

A1

E2
A2

C2

this chapter aims to understand the degree
of etiological overlap between PTSD and
specific ROIs the correlated factors model is
the best choice for these analyses.172

As

PTSD

ROI

Figure 1.3 Correlated Factors Twin Model

shown in Figure 1.3 the correlated factors
approach decomposes variances of variables into genetic (A) and environmental (C and
E) factors separately, and the correlations of the factors across the variables are estimated
(rA, rC, rE). The correlated factors approach allows the estimating of latent sources of
variance for both PTSD symptoms and ROI measures as well as the correlation between
the latent sources of each variable. Despite substantiated associations found between
PTSD and specific brain ROIs and their moderate heritability estimates, we still do not
know if covariation of these two phenotypes is due to overlapping genetic factors.
Without understanding the nature of this relationship, it will be more difficult to
comprehend how underlying mechanisms and genetic endophenotypes lead to
psychopathology. Therefore, the contribution of this chapter is significant because it will
be the first to formally test these ROIs as potential endophenotypes of PTSD.
Next, the role of trauma will be accounted for in this model via moderation on the
individual variance components. Since trauma is known to influence both PTSD and ROI
measures, we aim to understand PTSD and ROIs in the context of trauma exposure. By
understanding the interplay of trauma, genetic factors, ROIs, and PTSD in adults we will
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be able to better identify potential endophenotypes/risk-resilience factors present in nontrauma exposed adults.

The Shared Etiology of Fear and Anxiety in Juvenile Twins
Fear and anxiety are conceptualized as responses to acute or potential threat,
respectively. Adult twin studies have found substantial interplay between genetic and
environmental factors influencing fear disorders (phobias) and anxiety disorders.
Research in children, however, has largely examined these factors independently. Thus,
there exists a substantial knowledge gap regarding the underlying etiologic structure of
these closely-related constructs during development.

Given the partial distinction

between risk factors for phobias and other ADs in adults, it is important to examine their
childhood precursors. Furthermore, early fear and anxiety disorders are the strongest
predictors of later psychiatric comorbidity.173
Chapter 3 addresses this gap by examining measures of fear (as indexed by the
FSSC-RSF) and anxiety (as indexed by the SCARED) in a juvenile twin sample. The aim
of this chapter is to elucidate the shared and specific risk factors (genetic, familial
environment and unique environment) and their roles amongst fear and anxiety domains
in children. First, chapter 3 focuses on understanding the etiology shared between
anxiety symptom clusters on the one hand and the etiology shared between fear symptom
clusters on the other. Second, etiology shared between the anxiety and fear clusters is
examined via a correlated factors model similar to that in chapter 2.

Lastly, an

independent pathway model provides a more flexible and detailed representation of the
covariance structure between all of the clusters beyond the simple factor correlations
estimated in the correlated factors model. This set of analyses will investigate the
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underlying etiology of fear and anxiety symptoms and provide a possible reason for the
highly diffuse symptom patterns seen during development.

The Shared Etiology of Fear and Anxiety with Cortical and Subcortical
Structural Measures
One of the primary goals of the RDoC framework is to incorporate multiple levels
of information from genomics to circuits to self-report in order to understand the nature
of psychiatric illnesses. To incorporate this concept into this dissertation the last part of
this dissertation will incorporate the genetic findings from the previous chapter on selfreport measures with preliminary structural neuroimaging data. This will test whether
ROIs are potential endophenotypes for fear and anxiety in children.
To be considered an endophenotype a biomarker must be proven to associate with
the disorder, be heritable, and have a genetic relationship to the disorder identified
through either family, twin, or measured genotype based analyses.4 The neuroimaging
data available for this chapter is not sufficient for a well-powered twin study into the
heritability of ROIs specifically. However, by incorporating the results from chapter 3 it
is possible to create a genetic factor score indexing latent liability to fear/anxiety, which
can then be used to test whether ROIs have a genetically-based relationship with
fear/anxiety in children.
The genetic score is thought to be more proximal than phenotypic symptom
measures to the biological processes related to fear and anxiety measures, and as such
may provide a stronger link between fear and anxiety with ROIs. To test this hypothesis,
genetic factor scores indexing an individual’s latent liability to fear/anxiety are
incorporated into a mixed effect regression to predict ROI measures. A mixed effect linear
22

regression allows for the control of the non-independence of twin pairs by clustering
based on family and zygosity. This allows for more accurate estimations of confidence
intervals that would otherwise be artificially tighter due to the non-independence of
participants. Site of scanner, age, sex, and total intracranial volume will also be added to
the regression as fixed effect covariates. By examining the genetic factor score, chapter 4
aims to assess whether the ROIs are potential endophenotypes for fear and anxiety in
children.
As a post-hoc follow-up to these analyses, we will also test whether the fear and
anxiety total scale sum scores predict hippocampal volumes given prior findings. This
may elucidate whether either one of these scales is the main driving force behind findings
from the genetic score regressions. However, given our sample size and the complex
nature of both acquisition of neuroimaging data in children and highly comorbid
internalizing disorders, we are cautiously optimistic about any potential findings
remaining significant after multiple testing corrections. Regardless, these analyses would
be the first to examine these ROIs as potential endophenotypes for fear and anxiety using
a dimensional approach in children.
Overall, this dissertation will elucidate the etiological relationship between PTSD
and related traits (anxiety and fear) with specific brain ROIs in a trans-diagnostic
framework.

The primary gap in the current understanding of brain morphometry

endophenotypes is whether specific regions of interest (ROIs) have a genetic relationship
to disorders to which they are phenotypically associated. Investigating whether ROIs
meet endophenotypic criteria for PTSD, fear and anxiety will begin to fill these critical
gaps within the PTSD and child anxiety literatures. This knowledge will be particularly
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useful as the fields of neuroimaging and genetics continue to integrate and larger
neuroimaging datasets become publicly available.
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Chapter 2: The Moderating Role of Trauma on the Shared Etiology of PostTraumatic Stress Disorder and Brain Regions of Interest

This chapter addresses the first aim of this dissertation by examining the strength
of the relationship between post-traumatic stress disorder (PTSD) and brain regions of
interest previously implicated via functional and structural magnetic resonance imaging
(MRI). Given the accumulation of studies and meta-analyses that associate PTSD with
morphometric differences in the brain, it is a logical next step to investigate potential
shared etiology between PTSD and regions of interest (ROIs) with the goal of identifying
whether ROI morphometries meet the criteria for endophenotypes of PTSD. To identify
whether a biomarker is an actual endophenotype it must associate with the disorder, be
heritable, and have a genetic relationship to the disorder identified through either family,
twin, or measured genotypic analyses.4 The aim of this chapter is to assess whether ROIs
implicated in stress response meet the criteria for an endophenotype. Traumatic stress is
also associated with lasting changes in these areas and, as such, understanding the
interplay of trauma, genetics, ROIs, and PTSD in adults will better inform the ability to
identify potential endophenotypes/risk factors present in non-trauma exposed adults.

Regions of Interest
Thus far, functional neuroimaging studies have mainly examined differences
between PTSD and healthy controls with regards to activation of the fear-network and
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related cortical and subcortical areas.174 The more limited structural imaging literature
has also predominately used case/control study designs. PTSD symptoms are thought to
be the behavioral manifestation of stress-induced changes in function and structure of
these areas, which may also underlie the changes in endocrine and immune systems
associated with PTSD. As reviewed in Chapter 1, the hippocampus78,84,86, amygdala84,95,
areas of the PFC95,99, and ACC78,79,84,95,99 have varying degrees of support for their
involvement in PTSD, with generally smaller subcortical volumes (hippocampus and
amygdala) and thinner cortical thicknesses (vmPFC and ACC) found to be associated with
PTSD compared to healthy and/or trauma-exposed controls. The hippocampus and
vmPFC have conflicting or limited support, respectively, for their structural differences
associated with PTSD. By contrast, the amygdala has gained more recent and consistent
support from large meta-analyses.84,95 Finally, the ACC has the most conclusive evidence
for grey matter atrophy associated with PTSD67,78,84,95,97–99,175. Given the previous
literature, it is hypothesized that PTSD will be significantly associated with reduction in
volumes of the hippocampus and amygdala as well as thinner average cortical thicknesses
for the ACC and areas of the PFC: the lOFC, and mOFC. The literature appears to be fairly
consistent regarding an inverse direction of association for amygdala and ACC with PTSD
and as such these areas appear to hold the most potential for significant findings in these
data. There appears to be more conflict in the literature regarding hippocampus and PFC
areas (lOFC and mOFC), therefore non-significant findings in these areas would not be
surprising.
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Trauma
Exposure to a traumatic experience is necessary but not sufficient for a diagnosis
of PTSD.1 Previous research shows there are heritable risk factors for PTSD, with some
twin studies estimating that 30-72% of the variance of PTSD is accounted for by genetic
factors with the remaining variance accounted for by environmental factors unique to
each twin.28–31,176 Trauma in the context of combat exposure is known to partially
account for the prevelance177 and chronicity178 of PTSD, with those who experienced the
highest levels of combat exposure continuing to experience elevated PTSD symptom
levels up to 25 years after the exposure. Likewise, in noncombat trauma children with
the highest levels of exposure to a hurricane experienced higher levels of PTSD
symptoms in a dose-response manner.179 Given that not all who are exposed to
traumatic events develop PTSD, it is plausible that these experiences interact with facets
of an individual and affect their liability towards PTSD.
According to the diathesis-stress model of PTSD, an individual’s premorbid risk
factors interact with a stressor to produce a PTSD outcome.55 One possible route for this
interaction is if a traumatic event specifically interacts with underlying genetic liability
for PTSD and increases the risk for the disorder. This would be an example of gene by
environment interaction (GxE). In this case GxE implies the effect of exposure to trauma
is conditional on a person’s genetic liability towards the disorder. Trauma is thought to
change the heritability of PTSD via two hypothetical routes.180 In one, combat exposure
could increase the heritability of PTSD by causing the underlying differences in genetic
risk to manifest their effects. Only under certain environmental conditions might a
genetic predisposition manifest. A study using the full Vietnam Era Twin Registry found
just that when examining the moderating role of an ordinalized combat exposure measure
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on the heritability of PTSD diagnoses.180 In this study, as theorized, the influence of
trauma exposure was stronger in those with higher levels of trauma. In the other route,
combat exposure could ultimately decrease heritability of PTSD in a scenario where the
severity of the trauma is great enough that it overwhelms any potential genetic effects so
that essentially anyone who is exposed develops PTSD, regardless of their genetic
predisposition.181
In addition to genetic liability interacting with combat exposure to affect risk of
PTSD, the influence of environmental factors on PTSD risk may vary depending on the
level of combat exposure. These environmental effects can be shared between twins
(familial environment CxE) or unique to an individual (unique environment ExE). Twin
studies that incorporate moderation allow for the examination of GxE, CxE and ExE
effects. Combat exposure could increase the influence of other environmental factors
such as previous trauma from childhood or civilian life. Similar to genetic influences, the
environmental influences may decrease in the presence of combat exposure due to
extreme exposure overriding any other environmental protective/risk factors for PTSD.
One study that previously examined the effect of trauma due to combat exposure on PTSD
found the influence of heritability and unique environment increased at higher levels of
combat exposure.180 That is to say, those with the most severe combat exposure levels
were at an increased risk of PTSD due to interactions with both genetic and environmental
factors.
The effects of trauma exposure on brain morphology and circuitry without a later
diagnosis of PTSD or other psychopathology are not commonly examined. However,
well-designed studies do compare PTSD to healthy controls as well as to trauma-exposed
controls, and this is often where understanding of trauma-specific effects derives. Of
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studies conducted in this manner, meta-analyses have found bilateral reduction in
hippocampal volume78,84 in trauma-exposed controls versus healthy controls as well as
reduced amygdalar volumes.

79

Those exposed to trauma early in life had smaller ACC

volumes compared to controls and suggests this early trauma exposure may influence the
developing brain.107 Studies have shown that trauma is associated with morphometric
differences in the brain, and a twin study demonstrated trauma’s moderation of the
genetic and environmental influences on PTSD. Therefore, it is important to account for
the potential role of trauma when examining the relationship between PTSD and ROIs.
Study Aims
The aims of the present chapter are to 1) identify brain ROIs previously implicated
in PTSD that are significantly associated with PTSD sum scores in this sample; 2) examine
the genetic and environmental bases for significantly associated ROIs and PTSD symptom
sum scores; and 3) examine the extent to which trauma interacts with the shared genetic
and environmental factors of PTSD and ROIs associated with PTSD. Aim 3 allows the
examination of competing hypotheses about the effect of trauma on PTSD and ROIs.
These aims will be addressed by using mixed effect linear regressions and correlated
factor twin models.

Methods
Participants
Participants in this study are middle-aged male twins who participated in Wave 2 of
the Vietnam Era Twin Study of Aging182 (VETSA) with a mean age of 61.72 (SD = 2.45) at
time of assessment. All VETSA participants served in some branch of the military
between 1965 and 1975 with a mean age of entry to the military of 19.30 years (SD = 1.38),
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with the majority of the sample not serving in combat or in south east Asia. This sample
is 88.3% non-Hispanic white, 5.3% African American, 3.4% Hispanic, and 3% “other”,
and is very similar to American men in this age range with respect to health and lifestyle
characteristics.183 There was no selection criteria for this sample from the Vietnam Era
Twin Registry beyond safety measures required for the MRI portion of the protocol, such
as no metal present in the body. The University of California San Diego ethics committee
approved this study, and written consent was obtained from all participants.
Measures
PTSD
PTSD symptom counts were measured
using the PTSD symptom checklist at wave 2
This

scale

consists

of
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retrospective items of symptoms experienced
within the last month on a Likert scale (1 = ‘not
at all’ to 5 = ‘extremely’).

Count

assessment.

150

100

50

Sum scores were

calculated for those missing less than 10% of

0
30

50

70

Posttraumatic Stress Symptom Count

their responses by prorating for the number of
non-missing responses, with less than 2% of the

Figure 2.1 Histogram of
Posttraumatic Stress Symptom Counts

sample exceeding this missingness threshold.
Sum scores range from 17 to 84 (Mean= 26.36 SD= 10.66, skew= 2.02) with a higher score
indicating higher levels of PTSD symptoms and had good internal consistency with a
Cronbach’s alpha = 0.94. Within this sample a total of 94 participants (7.8%) meet
criteria for a probable PTSD diagnosis based on DSM- IV criteria, which is consistent with
PTSD rates seen in the general population as well as in other samples of Vietnam era
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veterans.184,185 This sample contains both individuals who served in southeast Asia as well
as those stationed elsewhere and as such a lower prevalence rate is expected when
compared to samples of only Vietnam theater veterans or more contemporary veteran
populations.
Combat Trauma Exposure
To quantify combat trauma, the 18- item
Combat Exposure Index was used, which
750

study, the Survey of Health.

Participants

completed this index at a mean age of 37.46 years

Count

participants completed by mail as part of a prior
500
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old (SD = 2.49) with a mean time since military
service of 18.16 years.. The mean age at military

0
0

service was 19.30 years (SD = 1.38). This index
assessed personal history of specific combat roles
and

experiences

that an

5

10
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Combat Experiences

Figure 2.2 Histogram of Combat
Experience Counts

individual could

experience during the Vietnam War including flying in aircraft or helicopter attacks,
serving on river patrols, receiving incoming fire, and being captured or wounded. The
Combat Exposure index has demonstrated good internal consistency and predictive
validity.186 Total number of endorsed experiences ranged from 0 to 16 (Mean = 1.48, SD
= 2.82, skew = 2.16). Figure 2.2 shows a histogram of total endorsed combat experiences.
Civilian and childhood trauma were not assessed by measures used in these analyses.
Additionally, this measure only accounted for combat situations experienced in the
Vietnam theater. However, only 30% of this sample were stationed in southeast Asia at
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some point during their military service, which partly accounts for the lower level of
trauma exposure compared to more contemporary veteran samples. Of those stationed
in southeast Asia the mean number of combat exposures was 5.49 (SD = 3.13, skew = .63).
Due to the moderating role of trauma, those without combat exposure data (incomplete
or missing combat exposure index data) were excluded from these analyses. A total of
1,207 individuals have PTSD and combat exposure data.
MRI acquisition
MRI scans were collected as part of the wave 2 assessments at two sites: University
of California, San Diego (UCSD) and the Massachusetts General Hospital (MGH).
Imaging and questionnaire data were assessed during the same visit and both twins were
present on the same days. At UCSD a General Electric 3T Discovery 750 scanner with an
eight-channel phase array head coil was used. Imaging protocol included sagittal 3D fast
spoiled gradient echo (FSPGR) T1-weighted volume optimized for maximum gray/white
matter contrast with the following parameters: TE= 3.164 msec; TR= 8.084 msec;
TI=600 msec; flip angle=8°; pixel bandwidth=244.141; FOV=24 cm; frequency=256;
phase =192; slices=172; slice thickness=1.2mm. At MGH a Siemens Tim Trio with a 32channel head coil was used. The imaging protocol included a 3D magnetization-prepared
rapid gradient-echo (MPRAGE) T1-weighted volume optimized for maximum gray/white
matter contrast with the following parameters: TE=4.33 msec; TR=2170 msec; TI= 1100
msec; flip angle=7°; pixel bandwidth= 140; slices= 160; slice thickness=1.2mm. A total
of 584 twins were scanned across the two sites.
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MRI Processing
The processing of the structural MRI images is described elsewhere in further
detail169. Processing of images was performed using standard, automated procedures
available in the Freesurfer image analysis software suite, which is freely available for
download and fully documented (Version 6.0, http://surfer.nmr.mgh.harvard.edu/).
Processing consisted of motion correction187, correction of distortion due to gradient
nonlinearity and B1 field inhomogeneity, image intensity normalization188, removal of
non-brain tissue using a hybrid watershed/surface deformation procedure189, and
automated Talairach transformation. FreeSurfer software package routines190,191 were
used to define gray matter, white matter, segmentation of subcortical structures, and
cerebral spinal fluid segmentation.

The procedures used for cortical thickness

measurement have been validated against histological analysis192 and manual
measurements193,194. After image processing subcortical volume and average cortical
thickness data were available from 447 twins (110 monozygotic twin pairs, 75 dizygotic
twin pairs and 77 singletons). The most common reason for exclusion of a scan was due
to excessive motion in the scanner which prohibited accurate assessment of brain
morphometry.

Cortical and Subcortical Measures
Prior to all analyses, all ROIs were regressed on age, scan site, and estimated
intracranial volume to remove the fixed effects of these covariates, i.e., the residuals were
used in subsequent analyses. The ROIs examined in this chapter include hippocampal
volume (N = 398), amygdala volume (N = 402), rostral anterior cingulate cortex (rACC;
N = 397) mean thickness, caudal anterior cingulate cortex (cACC; N= 397) mean
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thickness, lateral orbitofrontal cortex (lOFC; left hemisphere N = 396, right hemisphere
N = 397) mean thickness, and the medial orbitofrontal cortex (mOFC; N = 397) mean
thickness. Due to bilateral asymmetry within the brain the left and right hemispheres of
each of these regions were analyzed separately, for a total of 12 ROIs.

Statistical Analyses
Mixed Effect Linear Regression
As a preliminary analysis, mixed effect linear regressions were used to identify
which brain ROIs previously implicated in PTSD were associated with the PTSD symptom
sum score in this data. Given the inconsistent nature of the extant literature significant
associations for all ROIs were not expected in this dataset. Therefore, preliminary
analyses were needed to identify significant ROIs to perform the primary analyses of this
chapter. Random effects models were used to adjust for possible effects of correlated
observations in the twin data. In each model, family ID and zygosity respectively denoted
family membership and whether the pair was monozygotic or dizygotic and were entered
as random effects. The umx R package195 was then used to obtain 95% confidence
intervals for all standardized beta estimates.

Twin Modeling
This study used the classic twin design, which leverages the differences between
MZ and DZ twin types to decompose phenotypic variation into additive genetic (A),
common environmental (C), and unique environmental (E) factors196. Because MZ twins
share 100% of their genes and DZ twins share, on average, 50% of their segregating genes,
genetic factors contribute twice as much to the MZ twin correlation than to the DZ twin
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correlation. Common environmental factors are shared factors that make twin pairs more
similar, regardless of their zygosity. Unique environmental factors are specific to the
individual and represent experiences not shared by twins and contribute to neither MZ
nor DZ twin correlations.

The unique environment component also captures

measurement error.
Correlated Factors Twin Model. There are several potential bivariate models
available to fit (e.g. Cholesky, correlated factors, simplex etc.) and the model chosen
should depend on the underlying theory being tested172. Since this chapter hypothesizes
there are genetic and environmental overlaps between PTSD and specific ROIs, the
correlated factors model is the best choice for these analyses. It is possible to directly test
whether ROIs qualify as PTSD endophenotypes with this correlated factors approach. In
the correlated factors model, variances of variables are decomposed into genetic and
environmental factors separately, and the correlations of the factors across the variables
are estimated (rA, rC, rE). The correlated factors approach is specified for each latent
source of variance (genetic [A], familial environment [C], and unique environment [E])
and allows estimation of latent sources of variance for PTSD symptoms, ROI measures,
and the correlation between the latent sources of each variable. A low genetic correlation
would suggest PTSD and ROIs were influenced primarily by separate genes, and likewise
a high environmental correlation would suggest there exist environmental events that
influence both PTSD and ROIs.
Moderation. An underlying assumption of the classic twin model is that genetic
and environmental variance is consistent across environmental conditions (i.e.
homoscedastic). Heteroskedasticity arises when genetic and environmental factors vary
as a function of a moderator and represents genetic sensitivity to the environment.
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Moderators can be purely environmental (e.g., earthquakes), or another trait also under
some degree of genetic control (e.g., personality traits). Gene-environment interactions
can be parameterized in this model by having the variance decomposition of the trait (T)
as a linear function of a moderator (M), after accounting for the main effect of the
moderator variable on the trait. The moderator has a main effect on the trait (as seen in
the moderation of the mean of T), in addition to a moderating effect on the residual A, C,
and E variance components of the trait. In addition to A, C, and E estimates, β parameters
(accounting for the moderating effect of M on each path) are also estimated. A β
coefficient significantly different from zero would indicate the presence of moderation on
that variance component, with a larger β indicating a greater degree of moderation. It is
important to remember that not only is PTSD liability heritable, but trauma exposure is
also moderately heritable.30,49 This is an example of gene-environment correlation.197 To
account for gene-environment correlation the mean of T is regressed on M for both twins.
This approach reduces false positive GxE effects for two main circumstances 1) when M
and T are correlated with each other and 2) when M is correlated across twins. False
positive inflation can occur when the moderator is correlated between twins.198
Three primary biometrical models were examined that investigated: 1) the etiology
of PTSD; 2) the shared etiology of PTSD and ROIs; and 3) the shared etiology of PTSD,
ROIs moderated by trauma. For each of the primary models, submodels were tested by
dropping parameters and comparing the fit statistics to the full model (Model 1) to
determine the best-fitting model. A full information maximum likelihood approach for
raw data implemented in the OpenMx software was used.199 Model fits were compared
using the difference in negative two log-likelihood (Δ-2LL) for nested models, and with
Akaike Information Criterion (AIC) for non-nested models with lower values indicating a
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better fit.200 Under certain regularity conditions, Δ-2LL is distributed as χ2 with degrees
of freedom equal to the models’ difference in the number of free parameters.201 AIC is an
index that balances explanatory power with parsimony. Parsimony is an important
consideration in maximum likelihood approaches because log-likelihoods will continue
to decrease with additional parameters estimated, resulting in “overfitting”.

AIC

penalizes models with many parameters once they improve fit by less than 2LL units, and
provides an appropriate balance between model complexity and explanatory power as
manifest by the degree of misfit.202

Results
Mixed Effect Regression Analyses
Preliminary analyses were used to identify brain ROI associated with PTSD sum
scores from a list of potential brain ROI based on the extant literature and as such do not
correct for multiple-testing. Correlations between all variables are shown in Table 2.1.
Each ROI was examined in a separate analysis, and Table 2.2 summarizes the results. All
12 ROIs (six in each hemisphere) are listed with their corresponding standardized beta
estimate, confidence interval (CI), t- and p-values. Only three regions (right rACC, left
lOFC, and left mOFC) had confidence intervals that did not include zero and were
significantly associated with PTSD sum scores after accounting for the non-independence
of twin pairs. These three areas were then examined in bivariate twin analyses.
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Table 2.1 Correlations Between PTSD, Trauma, and Brain Morphometry Variables
Variables

1

2

3

4

5

6

7

8

9

10

11

12

13

14

1. PTSD
.23
<.001
-.01
.20
3. Age
.66 <.001
-.08
-.03
-.05
4. L Hipp
.12
.56
.32
-.11
-.04
-.04
.73
5. R Hipp
.02
.42
.47 <.001
-.01
.03
.00
.40
.36
6. L amyg
.81
.52
.97 <.001 <.001
-.03
.03
-.05
.37
.33
.58
7. R amyg
.57
.55
.29 <.001 <.001 <.001
-.04
.00
.11
.01
.01
.00
-.06
8. L cACC
.45
.96
.02
.88
.85
.95
.21
-.06
.00
.08
.04
-.03
-.10
-.08
.37
9. R cACC
.25
.95
.13
.43
.52
.04
.10 <.001
-.04
.14
.11
.08
.01
.03
-.01
.37
.34
10. L rACC
.42
.01
.03
.13
.78
.49
.87 <.001 <.001
-.14
0.4
.12
-.03
-.06
-.10
-.08
.31
.41
.36
11. R rACC
<.001
.42
.01
.50
.22 .05
.10 <.001 <.001 <.001
-.11
-.08
.00
.14
.08
.17
.07
.25
.33
.38
.28
12. L lOFC
.03
.03
.94 <.001 .10 <.001 .14 <.001 <.001 <.001 <.001
-.07
-.03
.05
.04
-.03
.02
.00
.31
.29
.36
.25
.65
13. R lOFC
.17
.63
.28
.43
.58
.65
.96 <.001 <.001 <.001 <.001 <.001
-.11
.06
.08
.02
.02
-.02
-.04
.29
.34
.45
.36
.45
.36
14. L mOFC
.03
.02
.13
.71
.75
.75
.44 <.001 <.001 <.001 <.001 <.001 <.001
-.07
.00
.12
.03 -.03
-.01
-.05
.24
.37
.42
.48
.49
.51
.43
15. R mOFC
.18
.94
.01
.61
.53
.81
.37 <.001 <.001 <.001 <.001 <.001 <.001 <.001
Correlations are reported in plain text, with p values reported below in italics for all variables.
2. Trauma
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Table 2.2 ROIs predicting PTSD Sum Scores in Separate Analyses
Region of Interest
β [95% CI]
t(151)
p
L Hippocampus
0 [0,0]
-1.68 .095
R Hippocampus
0 [-0.01, 0]
-2.22 .028
L Amygdala
0 [-0.01, 0]
-0.28 .744
R Amygdala
0 [-0.01, 0]
-0.78 .397
L rACC
-1.48 [-5.56, 2.59]
-0.72 .473
R rACC
-5.52 [-9.63, -1.20]
-2.54 .011*
L cACC
-1.27 [-4.95, 2.42]
-0.68 .498
R cACC
-2.03 [-5.95, 1.88]
-1.03 .307
L lOFC
-6.65 [-12.78, -0.41]
-2.10 .037*
R lOFC
-4.79 [-10.90, 1.31]
-1.55
.123
L mOFC
-6.44 [-12.59, -0.29]
-2.07 .040*
R mOFC
-3.41 [-8.92, 1.96]
-1.27 .221
β = standardized beta estimates, 95% CI = 95% confidence interval, L = left, R = right, rACC =
rostral anterior cingulate cortex, cACC = caudal anterior cingulate cortex, lOFC = lateral
orbitofrontal cortex, mOFC = medial orbitofrontal cortex. Using data from the Vietnam Era Twin
Study of Aging mixed effect linear regressions were performed

Twin Analyses of PTSD and Specific ROIs
To quantify the genetic and environmental influences on PTSD and each of the
three significantly associated brain ROIs, univariate and bivariate twin models were
fitted. Table 2.3 outlines the univariate models fitted to PTSD and each ROI. The first
section of Table 2.3 shows the results of fitting of univariate twin models to the PTSD sum
scores. The best fitting model for PTSD was the AE model with a standardized heritability
(a2) estimate of 0.36 (95% Confidence Intervals [95%CI]: 0.27, 0.44), and a unique
environment estimate of 0.64 (95%CI: 0.55, 0.73). The best fitting model for the right
rACC model was also AE; the heritability was 0.21 (95%CI: 0.0, 0.42), and unique
environment was 0.79 (95% CI: 0.60, 1.00). Lastly, the best-fitting models for the left
lOFC and mOFC were the AE models with heritabilities of 0.47 (95%CI: 0.31, 0.60) and
0.41 (95%CI: 0.25, 0.54), respectively, and unique environment estimates of 0.53 (95%CI:
0.39, 0.68) and 0.59 (95%CI: 0.44, 0.73), respectively.
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Table 2.3 Model fit statistics for Univariate PTSD and ROI Twin Models
Model Factors
Δdf
-2LL
AIC
p
Posttraumatic Stress Disorder Sum Score
I
ACE
1159
8753.63
6435.63
II
AE
1
8753.69
6433.69
.822
III
CE
1
8760.16
6440.16
.010
IV
E
2
8803.09
6481.09
<.001
Right Rostral Anterior Cingulate Cortex
I
ACE
388
-67.25
-843.25
II
AE
1
-67.18
-845.18
. 693
III
CE
1
-67.10
-845.10
. 786
IV
E
2
-63.30
-843.30
. 139
Left Lateral Orbitofrontal Cortex
I
ACE
387
-374.25
-1148.25
II
AE
1
-374.23
-1150.23
.898
III
CE
1
-371.31
-1147.31
.086
IV
E
2
-346.06
-1124.06
<.001
Left Medial Orbitofrontal Cortex
I
ACE
388
-357.87
-1133.87
II
AE
1
-357.85
-1135.85
.880
III
CE
1
-355.85
-1133.85
. 155
IV
E
2
-334.95
-1114.95
<.001
-2LL = -2 log-likelihood, Δdf = change in degrees of freedom from full model (I), ΔAIC = change
in Akaike Information Criterion from full model (I). For AIC and -2LL, smaller or more negative
values indicate a better fit compared to the full model (Model 1). p is related to the statistical
difference of -2LL values between full and sub models. Best fitting models are designated in bold
text for each section of analyses.

Bivariate correlated-factors models were fitted to PTSD and each of the three
significantly associated brain ROIs (Right rACC, Left lOFC, and Left mOFC) from the first
aim with model results shown in Table 2.4. Similar to the PTSD univariate model, an AE
model fit best in all three bivariate models (right rACC, left lOFC, and left mOFC). Figure
2.1 shows an example of the etiological structure of PTSD and each ROI, with
standardized variance and correlation information for each model shown in Table 2.5. All
three ROIs have minimal, nonsignificant genetic correlations with PTSD (0.05 to 0.10)
and moderate unique environmental correlations (-0.25 to -0.26).
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Table 2.4 Model Fit Statistics for Bivariate Correlated Factors Model of PTSD and
ROIs
Model
Factors
Δdf
-2LL
AIC
p
PTSD & Right rACC Bivariate Model
I
ACE
1544
8676.72
5586.72
II
AE
3
8676.96
5580.96
.971
III
CE
3
8684.64
5588.64
.047
IV
E
6
8732.68
5630.68
<.001
PTSD & Left lOFC Bivariate Model
I
ACE
1543
8371.72
5283.72
II
AE
3
8374.74
5280.74
.387
III
CE
3
8380.03
5286.03
.039
IV
E
6
8452.81
5352.81
<.001
PTSD & Left mOFC Bivariate Model
I
ACE
1544
8388.41
5298.41
II
AE
3
8390.43
5294.43
.567
III
CE
3
8396.32
5300.32
.042
IV
E
6
8464.32
5362.32
<.001
-2LL = -2 log-likelihood, Δdf = change in degrees of freedom from full model (I), AIC = Akaike
Information Criterion. rACC= rostral anterior cingulate cortex, lOFC= lateral orbitofrontal
cortex, mOFC= medial orbitofrontal cortex. For AIC and -2LL, smaller or more negative values
indicate a better fit compared to the full model (Model 1). p is related to the statistical difference
of -2LL values between full and sub models. Best fitting models are designated in bold text for
each section of analyses.

rE
rA
E1

E2

A2

A1

PTSD

ROI

Figure 2.3 Example Bivariate Correlated Factors Model for PTSD and ROIs.
A= Genetic Factor, C= Familial Environment Factor, E= Unique Environment
Factor, rA = genetic correlation between PTSD and ROI, rE =
environmental correlation between PTSD and ROI
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Table 2.5 Standardized Variance and Correlation Estimates for Bivariate Correlated
Factors Models between PTSD and each ROI
Unique
Genetic Factors
Environment Factors
A1
A2
rA
E1
E2
rE
Model (95%CI) (95%CI)
(95%CI)
(95%CI) (95%CI)
(95%CI)
R rACC
.36
.19
.12
.64
.80
-.16
(.27; .44) (.03, .38) (-.48, .21) (.55, .73) (.61, .98) (-.26, -.04)
L lOFC
.36
.45
.05
.64
.54
-.26
(.27, .44) (.28, .60) (-.27, .42) (.55, .73) (.41, .71) (-.43, -.06)
L
.36
.38
.07
.64
.63
-.25
mOFC
(.27; .44) (.22, .53) (-.28, .51) (.55, .73) (.55, .73) (-.42, -.05)
rACC= rostral anterior cingulate cortex, lOFC= lateral orbitofrontal cortex, mOFC= medial
orbitofrontal cortex. L = left, R = right, 95%CI = Confidence intervals. A1 and E1 factors load
onto the PTSD sum score, A2 and E2 factors load onto the ROI listed in the Model column. rA
and rE are the correlations between each factor. . Each model listed is the best-fitting model
from the corresponding sections of Table 2.2.

Moderated Bivariate Twin Analyses of PTSD, Specific ROIs, and Trauma
To address the final aim of this chapter, a moderated bivariate correlated factors
model was fit to the data with trauma as the moderator on PTSD and ROI variance
components as well as on the means. Given that there was no evidence for shared genetics
across PTSD and the ROIs (noted by the large confidence intervals that cross zero in Table
2.5) these covariances were constrained to zero as the models failed to converge when
they were freely estimated. Table 2.6 shows the fit statistics for models testing moderated
correlated factor models for PTSD and each ROI.

The moderators on variance

components were tested individually by adding them into the model one at a time rather
than starting with all being freely estimated. This is due to the fact the sample size was
too small to provide model stability when all moderators were freely estimated in the full
model. Therefore, model fitting began with an environment only (E) model and built up
to the AE model while adding moderation to a source of variance at each step as outlined
in Table 2.6. For the right rACC, models did not converge when incorporating moderation
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on the genetic factors, while for the left mOFC only moderation on the genetic factor of
the mOFC could be examined. For the left lOFC genetic moderation of both PTSD and
the ROI simultaneously was examined, but models did not converge when moderation on
both genetic and environmental factors was specified. The first section of Table 2.6 shows
that model I, an E model with moderation on the means and the environmental factors
fit best for PTSD and the right rACC. The best-fitting model of the left lOFC was model
IV, an AE model with moderation on the means and genetic factors. Lastly, model IV, an
AE model with moderation on the means and on the genetic variation in mOFC was the
best-fitting model for the mOFC. Table 2.7 shows the path estimates for the best-fitting
moderated model for each ROI. Figure 2.4 shows an example moderated bivariate model
with path labels corresponding to the estimates in Table 2.7.
Table 2.6 Twin Model Fit Statistics for Moderated Bivariate Correlated Factors Model
of PTSD and ROIs
Model Factors
Moderation
DF
-2LL
AIC
PTSD and Right rACC
I
E
E
1447 8117.94
5223.94
II
AE
1547
8676.96
5580.96
III
AE
E
1445
8164.48
5274.48
PTSD & Left lOFC
I
E
E
1447
11155.40
8261.40
II
AE
1547
8374.74
5280.74
III
AE
E
1445 10078.18
7186.17
IV
AE
A
1445 7934.21
5044.21
PTSD and Left mOFC
I
E
E
1447
7888.40
4994.40
II
AE
1547
8390.43
5294.43
III
AE
E
1445 7911.042
5021.04
IV
AE
AOFC
1446 7718.45
4826.45
-2LL = -2 log-likelihood, DF = degrees of freedom, AIC = Akaike Information Criterion. rACC=
rostral anterior cingulate cortex, lOFC= lateral orbitofrontal cortex, mOFC= medial orbitofrontal
cortex. For AIC and -2LL, smaller or more negative values indicate a better fit compared to the
full model (Model 1). p is related to the statistical difference of -2LL values between full and sub
models. Best fitting models are designated in bold text for each section of analyses.
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βEPTSD
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A1
βAPTSD

βEROI

βAROI

PTSD

ROI

Figure 2.4 Example Moderated Bivariate Correlated Factors Model for PTSD and
ROIs.
A= genetic factor, E= unique environment factor, rA = genetic correlation between
PTSD and ROI, rE = environmental correlation between PTSD and ROI, β A =
combat trauma moderation on genetic factor, β E = combat trauma moderation on
unique environment factor
β E= combat trauma moderation on Unique Environmental Factor

Table 2.7 Standardized Parameter Estimates For Each Moderated Bivariate Model
Parameter Bivariate rACC Bivariate Left lOFC Bivariate Left mOFC
Estimate [SE]
Estimate [SE]
Estimate [SE]
APTSD
0.03 [.08]
0.03 [0.08]
AROI
0.32 [.002]
0.40 [.002]
EPTSD
1.00 [.43]
0.97 [.04]
0.97 [0.04]
EROI
1.00 [.08]
0.68 [.002]
0.60 [.001]
rE
0.0 [.09]
0.00 [.08]
0.00 [.08]
β APTSD
0.045 [.19]
β AROI
-0.43 [.06]
.15 [.05]
β EPTSD
0.06 [.01]
β EROI
0.02 [.05]
A = additive genetic factor; E = unique environmental factor; β= moderation beta estimate on
specified variance component; PTSD = posttraumatic stress disorder, ROI = region of interest;
SE = standard error
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Discussion
The overall aim of this chapter was to assess whether ROIs implicated in stress
response meet the criteria for an endophenotype of PTSD. This was done by examining
the moderating role of trauma on the shared genetic and environmental structure of PTSD
and brain regions associated with PTSD. First, by using mixed effect linear regressions,
it was possible to identify brain ROIs associated with PTSD sum scores from a list of
potential brain ROIs based on the extant literature. Next, modeling of the shared etiology
of PTSD with each of the 3 surviving ROIs showed familial environment was not
significant for any of the phenotypes examined. Table 2.5 shows there was minimal to no
genetic correlation between PTSD and ROIs, and a small but significant negative
correlation between unique environmental influences of PTSD and each ROI. Lastly, we
examined whether trauma moderated the genetic or unique environmental influences on
PTSD and ROIs.
In the preliminary analyses of 12 potential ROIs only three were significantly
associated with PTSD, and had non-zero standardized beta estimates.

All of the

significantly associated ROIs had the expected direction of association: a reduction in
cortical thicknesses as PTSD sum scores increased. The mixed effect regressions found
the right rACC, left lOFC, and mOFC associated with PTSD symptoms. This is consistent
with previous meta-analyses which found reduced grey matter volume in the right
anterior cingulate gyrus (a sub-region of the ACC)163 and two other meta-analyses that
found significant associations with thinner OFC regions.95,99
For all non-moderated genetic modeling, the AE models provided the best fit,
suggesting that both genetic and unique environmental influences, but not shared
environmental influences contribute to the etiology of PTSD and brain morphology. This
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is consistent with previous studies that separately examined the etiology of PTSD28–30,
and brain morphology170. In the bivariate models PTSD and ROIs were found to have
overlapping unique environmental influences, but did not share genetic influences as
noted by the wide confidence intervals that cross zero. Within the statistical power of this
study, this finding eliminates ROI volume as a potential endophenotype for PTSD. This
is the first study to examine the potential shared etiology of PTSD symptoms and brain
morphology and, therefore, these results represent novel findings for the field of
neuroimaging genetics.
Analyses for the final aim added moderation to the previous bivariate models with
trauma as the moderator on PTSD and ROI variance components as well as on the means.
These models tested whether trauma exposure accounted for the associations observed
between PTSD and ROIs. Given that there was no evidence for shared genetic factors
across PTSD and the ROIs these covariances were constrained to zero as the models failed
to converge when included. The best fitting model for the ACC was an environment only
model (E), with moderation on the means and variances. An AE model was the bestfitting model for both the lOFC and mOFC, with moderation on both genetic factors for
the model including lOFC , and moderation on the ROI genetic factor only for the one
including mOFC.
Although there was significant genetic moderation specifically on PTSD within one
of the bivariate models, it was substantially smaller than previous studies.180 When
examined in a univariate model as a follow-up analysis, the moderation of trauma on the
heritability of PTSD was -0.42 (SE = 0.80), which was still roughly half of previous
findings. However, at minimum it does provide support for a diathesis-stress model of
PTSD together with the previous findings of combat exposure’s moderating role on PTSD.
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However, the strength of this relationship is not as strong in these analyses. There are
several potential reasons for this discrepancy such as a small sample size and timing
difference between assessment of combat exposure and PTSD symptoms.
The extended time between the assessments of trauma and PTSD may also further
reduce the ability to detected significant moderation. Although trauma recall is fairly
accurate, even with over a decade since the exposure203, there is a known slight inflation
in exposure reports when there is an increase in reexperiencing symptoms. Within a
latent class analysis of PTSD symptoms across time 4 main trajectories were identified:
delayed-onset, improving, elevated-recovering, and stable low symptom. All but one class
showed either low levels or decreasing levels of symptoms for both active and veteran
military personnel within a large sample (N = 22,080).204 This reduction in PTSD
symptoms across time combined with potential reporting biases of combat exposure
based on the current level of symptoms being experienced could negatively impact the
ability of this study to obtain accurate results.
Using an all-male sample may influence these findings as well.

Volumetric

differences between sexes205 and their potential implications for functional differences
may contribute, in part to the differential rate of specific symptom clusters between men
and women with women reporting more re-experiencing, avoidance, and hyperarousal
symptoms206. Additionally, sex steroids are involved in structural plasticity of regions
involved in the stress response207, i.e. the hippocampus and amygdala, leading to slight
differences in the physiological stress response between the sexes.208 Based on previous
literature of known sex differences in symptoms, brain morphometry, and physiological
stress response these analyses could have different results within a sample of women.
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However, of the results obtained in this study the most interesting result of the
moderated models is that inclusion of the combat exposure moderator completely
removes the previous environmental correlations between PTSD and each ROI. This
supports the hypothesis that the correlations between PTSD and ROIs are to some degree
accounted for by combat exposure experienced by the twins. For the lOFC it appears that
combat exposure decreases the heritability estimates at higher levels of combat exposure.
For the mOFC, combat exposure increases the heritability of the mOFC at higher levels of
combat exposure.
Although close in proximity, the lateral and medial sub-regions of the OFC are
cyto-architecturally distinct, displaying different connectivity patterns209–217, and there is
support for divergent functions in learning and decision-making tasks218 between them.
However, their functionality has not been unequivocally established in humans or other
animal models. In a meta-analysis of connectivity modeling, the lOFC showed coactivation with other regions in the PFC involved in cognitive functions and memory. It
is possible that in addition to being one of the regions with higher heritability219,220, the
mOFC is also more sensitive to trauma exposure. Given the greater degree of genetic
influence and the relationship with learning and memory, individuals who were
genetically vulnerable to trauma exposure would be more sensitive to the pathological
effects of trauma. For the mOFC this would likely manifest as impairments in and failure
to re-establish fear regulation221 and lead to PTSD-like symptoms.
This chapter is unable to directly test mechanisms by which combat exposure
modifies the strength of genetic and environmental liabilities for PTSD.

However,

epigenetics is one possible mechanism222 by which environmental factors could affect
genetic influences on a trait (i.e. GxE) and has been previously implicated in PTSD.223,224
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Potentially, combat exposure could function through epigenetic mechanisms to cause
gene expression changes that affect neuroprocesses, which then lead to atrophy of cortical
thickness in areas involved in the processing of traumatic events (i.e. the ROIs examined
in this chapter) and ultimately lead to the development of PTSD. If this were to happen,
PTSD and ROIs would appear to be environmentally correlated, however once trauma
exposure (and indirectly its effect on epigenetic mechanisms) is accounted for, the
correlation would disappear. Further research involving thorough phenotyping of trauma
type and timing, as well as epigenetics and neuroimaging is necessary to further test this
possible explanation of these results.
These findings should be interpreted in the context of several potential limitations.
First, this sample contained only male middle-aged participants, so the results may not
generalize to women, or younger populations. Second, all MRI data were obtained at two
sites. This was accounted for in analyses by regressing out any contributions related to
site of scan, but this does not include possible random effects of site (the number of sites
is too few for this type of correction). It should also be noted that each twin was scanned
at the same site as their co-twin, and there were equal mixes of MZ and DZ twin pairs
scanned at each site. Additionally, participants were assessed for PTSD symptom severity
and combat exposure levels at separate time points, approximately 50 and 30 years after
service in the Vietnam War. Although the PTSD items assessed symptomatology in the
past 30 days, the delay between combat exposure and its measurement for this study does
raise questions about recall bias in participant self-report measures of combat exposure.
Lastly, although overall VETSA has a relatively large twin sample, PTSD is not as common
as other psychopathology27, therefore this study has reduced power to detect significant
findings in ROI-based analyses of PTSD compared to other psychiatric disorders.
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However, this is a common issue for samples that are not explicitly enriched for
phenotypes. This issue became especially apparent when fitting the last series of models
containing moderation, as the larger models with more parameters did not converge.
Therefore the results from the final aim should be interpreted with the understanding
that they are most likely underpowered. Larger consortia-based analyses, such as those
associated with the enhancing neuroimaging genetics through meta analyses (ENIMGA)
consortium may be better suited to obtained more precise estimates of shared etiology.
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Chapter 3: The Genetic and Environmental Structure of Fear and Anxiety in
Juvenile Twins
Fear and anxiety are adaptive responses to acute or potential threat,
respectively.153

When symptoms become dysregulated, excessive, or interfere with

functioning and quality of life, fear and anxiety symptoms are considered clinical phobias
or other anxiety disorders, respectively.1 As disorders of threat response with some
shared features, psychiatric nosology traditionally includes phobias, generalized anxiety,
and panic within the anxiety disorder domain. Both domains have roots in childhood but
commonly expand and persist into adolescence and adulthood, accounting for a
substantial proportion of lifetime psychiatric illness.6 However, due to their individually
broad but partially distinguishable features and complex unfolding across development,
researchers have often separately investigated various aspects of their symptomatology at
different ages.
Fear represents the emotional-behavioral response to the perception of immediate
danger, leading one to avoid the threat for discernible survival value.108 Fears and
phobias are highly comorbid123, and twin studies suggest this may be explained, in part,
by overlapping genetic and environmental influences120,225. One twin study investigating
the comorbidity structure of fear symptoms in children reported a common genetic factor
that influenced all clusters in addition to fear-specific factors.124
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Anxiety disorders (ADs) often have a basis in normal anxious concerns; however,
the degree of anxiety and associated symptoms may become excessive, uncontrollable,
and impairing to an individual’s life. ADs are highly comorbid with each other, and adult
twin studies suggest that this comorbidity may be due, in part, to genetic risk factors
shared between disorders.149,150 This comorbidity pattern is also seen in children, where
40% to 60% of children with one AD are estimated to meet criteria for additional
ADs.151,152
In a non-twin study, Muris and colleagues226 report substantial correlations
between subscales of the Fear Survey Schedule for Children-Revised (FSSC-R)114 and the
Screen for Child Anxiety-Related Emotional Disorders (SCARED).143 However, only a few
studies of children have examined the liability structure of DSM-based anxiety
dimensions146 or phobic fear symptoms.119,124 No child twin studies have explored the
potential sources of shared etiology of these two threat response domains. Given the
partial distinction between risk factors for phobias and other ADs in adults, it is important
to examine their childhood precursors. Furthermore, early fear and anxiety disorders are
the strongest predictors of later psychiatric comorbidity.173 Therefore, this chapter aims
to explicate the shared and specific risk factors (genetic, familial environment and unique
environment) and their roles amongst fear and anxiety domains in youth. Due to the
moderate level of correlation between the FSSC-R and SCARED subscales described
above, partial overlap between genetic and environmental factors across these scales is
predicted.

By leveraging symptom sum scores rather than diagnostic criteria, the

statistical power to detect meaningful patterns of shared and specific variance is likely to
be increased.
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Methods
Participants
The twins included in these analyses comprised the VCU Juvenile Anxiety Study
(VCU-JAS).227 Using twin families recruited by the Mid-Atlantic Twin Registry228, VCUJAS enrolled twins aged 9-14 across two sites (VCU and the National Institute of Mental
Health; NIMH) to participate in a study of internalizing phenotypes. Only Caucasian
twins were recruited to minimize heterogeneity within the sample for the genetic aims of
the overall study. The Institutional Review Boards at VCU and NIMH approved this
study, and parents of all participants provided informed consent before participating.
Self-report data available for this study came from 746 youths (N=130 monozygotic (MZ)
twin pairs and N=243 dizygotic (DZ) twin pairs) consisting of 388 female and 358 male
twins. Zygosity was determined using parental responses to standard questions about
physical appearance of the twins and DNA testing as described in detail elsewhere.227

Measures
Fear
The FSSC-R114 is a widely used questionnaire for assessing common fears in
children.112,118,229 It uses a 3-point Likert scale (1=‘none’, 2=‘some’, 3=‘a lot’) for each of
80 feared stimuli or situations. The shortened 25-item form (FSSC-RSF) has a 5-factor
structure similar to the full scale230, and a confirmatory factor analysis (CFA) using Mplus
version 7.4231 demonstrated an adequate fit for our data (CFI= .88, RMSEA= .06)
consistent with previous literature.

The five subscales included fear of failure and

criticism (CRIT), fear of the unknown (UNKN), fear of animals (ANML), fear of danger
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and death (DEATH), and medical fears (MED). A sum score was calculated for all
subscales with the following means (standard deviations): CRIT 8.51 (2.43), UNKN 7.68
(2.38), ANML 7.28 (2.02), DEATH 12.96 (3.41), and MED 6.85 (2.06). Figure 3.1 shows
histograms for each subscale and the total scale, with the mean of each denoted by a blue
line. Prior studies have found the FSSC-RSF has good internal consistency, total score
Cronbach’s alpha=0.91, and subscale alpha=0.74-0.82230, with full-scale alpha=0.96 and
two-week test-retest reliability=0.78 found in our sample227.
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Figure 3.1 Histograms FSSC-RSF Subscales and Total Sum Score Counts
Sum scores for each subscale and total sum score are shown with blue line indicating the mean
of the subscale.

Anxiety
The SCARED was developed to screen for ADs within clinical samples142,143 but has
also been widely used in community and research studies.144,145 It assesses five clusters
of childhood anxiety symptoms: panic/somatic [PAN], generalized anxiety [GAD], social
anxiety [SOC] and separation anxiety [SEP] as well as school avoidance. The 41-item
version142 assesses symptoms on a 3-point Likert scale. (0=‘almost never’, 1=‘sometimes’,
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Figure 3.2 Histograms SCARED Subscales and Total Sum Score Counts
Sum scores for each subscale and total sum score are shown with blue line indicating the mean
of the subscale.

2=‘often’). As intended, the factor structure for the scale yielded five subscales: PAN,
GAD, SEP, SOC, and School Avoidance. Since School Avoidance is not related to a specific
DSM-IV disorder, we did not use it for our analyses. A CFA excluding the school
avoidance items showed a four-factor model fit our data adequately (CFI=.92,
RMSEA=.04) consistent with previous literature.232 A sum score was calculated for each
of the four DSM-related subscales with the following means (standard deviations) in
VCU-JAS: PAN 5.17 (3.86), GAD 5.94 (3.69), SEP 5.20 (3.42), and SOC 6.00 (3.29); for
more information see.227 Figure 3.2 shows histograms for each subscale and the total
scale, with the mean of each denoted by a blue line. Previous studies found a high degree
of internal consistency of the SCARED (Cronbach’s alpha=0.74-0.93) and good test-retest
reliability (intraclass correlation coefficients=0.70-0.90).142,143

Our sample found a

similar full-scale Cronbach’s alpha=0.90 and two week test-retest reliability=0.89.
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Statistical analyses
Analyzing the similarity of MZ and DZ twins can elucidate the roles of additive
genetic (A), familial environmental (C), and unique environmental (E) effects. Variance
is partitioned into underlying genetic and environmental influences by leveraging the
difference in genetic relatedness between twin types. Additive genetics (A) reflects the
latent cumulative effects of individual genetic loci influencing a trait.

Familial

environment (C) captures non-genetic influences that make twins more similar to each
other compared to the general population. Unique environment (E) describes influences
that contribute to the differences seen between co-twins, including measurement error.
Models were fitted by full information maximum-likelihood (FIML) using the OpenMx
package.199
In multivariate structural equation modeling, ACE components can be specific to
each subscale (e.g., As1 in Figure 3.3) or common to multiple subscales (e.g., Ac1). Age
and sex have a substantial effect on fear and anxiety measures and were included as fixedeffect covariates for all phenotypic means. Due to sample size we do not have the power
to examine sex effects on variances, however inclusion of age and sex as covariates on the
means is a step towards reducing the heterogeneity introduced by these covariates.
Significance of individual parameters was tested by comparing the fit of a model to that
of a constrained submodel.

Likelihood ratio χ2 tests are used to determine if the

constrained model fits the data significantly worse than the saturated model. AIC is based
on twice the difference in log-likelihood between higher order and submodels with a
penalty for degrees of freedom, with lower AIC denoting a better balance of model fit and
parsimony.202
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An increasingly complex series of hypothetical models were fit to the data.
Multivariate independent pathway models (IPMs), and common pathway models (CPMs)
were estimated separately for each scale to estimate their sources of variance and
covariance. Second, we tested whether the common ACE factors for the best-fitting FSSCRSF were correlated with those of the SCARED via a correlated factors model (CFM).
Non-zero correlations provide evidence for shared etiology across fear and anxiety
domains in children. The final model, a combined IPM covering both sets of symptom
clusters, provided a more nuanced representation of the covariance structure beyond the
factor correlations in the CFM. We tested the need for multiple sets of common ACE
sources of covariance to explain the observed data.

Results
Fear
The Fear sections of Table 3.1 displays the fit statistics for the independent and
common pathway models of the FSSC-RSF. To test for genetic and environmental factors
common to all subscales, we began with a model including single common A, C, and E
factors plus specific ACE factors with age and sex covariates for each subscale mean.
Significance of common and then specific factors were sequentially tested by iteratively
constraining parameters to zero. Common pathway models consisting of 1-, 2-, and 3factors were fit to the data as well. As indicated in Table 3.1, Model 1b was determined to
be the best fitting and most parsimonious model. It included a single set of common ACE
factors and subscale specific A and E factors. Females had the expected pattern of higher
mean subscale scores compared to males across all subscales, depicted in Figure 3.3 as
paths from the sex moderator (lower right circle) loading on each subscale. A slight
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decrease in means as age increases for all scales except for criticism is consistent with
decreases in childhood fears over development. The influence of common and specific
genetic factors accounted for 10-34% of the total of variance of each subscale with the
remaining variance accounted for primarily by subscale specific, unique environmental
factors. As a follow up to the two-factor common pathway model, which fit almost as well
as Model 1b in Table 2.1 of the independent pathway series, a series of independent
pathway models were fit to the data with two sets of common ACE factors. However, they
were unable to converge on a final solution. As such analyses moved forward with the
best-fitting model containing a single set of ACE factors.

Anxiety
The Anxiety sections of Table 3.1 displays the fit statistics for the independent and
common pathway models of the SCARED. Similar to fear, we found model 1b of the
independent models fit best with single set of common ACE factors and subscale specific
A and E. Age and sex influenced the means of each subscale in a similar pattern to fear.
GAD was the exception for which the opposite age trend was found, consistent with
clinically observed increased risk of GAD with age. The total influence of all genetic
factors accounted for 18-35% of each subscale’s variance with remaining variance
accounted for primarily by subscale specific unique environmental factors. The genetic
factor common to all subscales accounted for 5-19% of the variance for PAN, GAD and
SEP. Only SOC did not share genetic influences with the other symptom clusters. Figure
3.4 depicts the path estimates from the best fitting model for the SCARED.
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Table 3.1 Model-Fitting Results for Multivariate Independent Pathway Models of Fear
and Anxiety
Fear Independent Pathway Models
Model Fit
Common
Specific
df/Δ
-2LL
AIC
P
Model
Factors
Factors EP
1
A1C1E1
All ACE
45
3612
15553.6
8349.6
1a
A1C1E1
All AE
40
5
15553.6 8339.6
.999
1b
A1C1E1
All CE
40
5
15558.6
8344.6
.413
1c
A1C1E1
All E
35
10
15569.2
8345.2
.110
2
C1E1
All ACE
40
5
15569.7
8355.7
.000
3
A1E1
All ACE
40
5
15560.8
8346.8
.204
4
A1C1
All ACE
40
5
15714.8
8500.8
.000
5
All ACE
30
15
16455.7
9221.7
.000
Fear Common Pathway Models
6
1 Factors
All ACE
38
15572.5
8354.5
3609
7
2 Factors
All ACE
46
15552.8
8350.8
3601
8
3 Factors
All ACE
54
15538.6
8352.6
3593
Anxiety Independent Pathway Models
1
A1C1E1
All ACE
36
2900
14824.0 9024.0
1a
A1C1E1
All AE
32
4
14824.0 9016.0
.999
1b
A1C1E1
All CE
32
4
14837.6 9029.7
.008
1c
A1C1E1
All E
28
8
14852.6 9036.7
.000
2
C1E1
All ACE
32
4
14833.4 9025.4
.005
3
A1E1
All ACE
32
4
14836.1 9028.1
.001
4
A1C1
All ACE
32
4
14951.4
9143.4
.000
5
All ACE
24
12
15544.1
9720.1
.000
Anxiety Common Pathway Models
6
1 Factors
All ACE
31
14836.7 9024.7
2905
7
2 Factors
All ACE
38
14827.1
9031.1
2898
8
3 Factors
All ACE
45
14823.0 9041.0
2891
Abbreviations: EP=estimated parameters, df /Δ= degrees of freedom for model and change in
degrees of freedom for submodels, -2LL = twice the negative log likelihood of model, AIC =
Akaike information criterion of model. For AIC and -2LL, smaller values indicate a better fit
compared to the full model (Model 1). p is related to the statistical difference of -2LL values
between full and sub models. Bold designates the overall best fitting model.
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Figure 3.3 Best-Fitting Model for Fear Subscales
The model contains 1 common additive genetic factor (Ac1), 1 common familial environmental
factor (Cc1), and 1 common unique environmental factor (Ec1). Only subscale specific additive
genetic, and unique environmental factors were found to be significant, and thus retained in
the final model. Path coefficients representing standardized estimates are listed above 95%
confidence intervals for each path for fear of failure and criticism (CRIT) fear of the unknown
(UNKN), fear of animals (ANML), fear of danger and death (DEATH), and medical fears
(MED). Triangles in the middle figure denote age and sex moderators on the means for all
subscales, with 95% CIs listed below the standardized path estimate. Triangle (µ) represents
the means [S.D.] of the four subscales in addition to loading onto the covariates age and sex
[95% CI]
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Figure 3.4 Best-Fitting Model for Anxiety Subscales
The model contains 1 common additive genetic factor (Ac1), 1 common familial
environmental factor (Cc1), and 1 common unique environmental factor (Ec1). Only
subscale specific additive genetic, and unique environmental factors were found to be
significant, and thus retained in the final model. Path coefficients representing
standardized estimates are listed above the 95% confidence intervals (CIs) for each path
for panic disorder (PAN), generalized anxiety disorder (GAD), social phobia (SOC) and
separation anxiety (SEP). Triangle (µ) represents the means [SD] of the four subscales in
addition to loading onto the covariates age and sex [95% CI]
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sex

Modeling Across Fear and Anxiety
Correlated Common Factors Model
We used the best fitting individual IPMs of Fear and Anxiety to examine the
overlap in their etiology via correlations between the two sets of common ACE factors.
Each subscale retained specific ACE factors to capture residual variance not otherwise
accounted for by common factors. Model 1 in Table 2 freely estimated all correlations,
and submodels tested significance of each correlation by constraining to 1 (fully shared)
or 0 (no sharing) and comparing fit to the full model. Model 12 had a slightly better fit to
these data, with the correlation between common familial environment factors and the
correlation between common genetic factors constrained to 1 plus a common unique
environmental factor correlation estimated at r=0.67. Consistent with the single scale
models, it included significant age and sex effects on the means. Statistically stable
specific influences on the subscales and highly correlated influences common to all fear
and anxiety clusters motivates a more detailed examination of the risk structure via the
combined independent pathway model.
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Table 3.2 Model-Fitting Results for Correlated Common Factor IPM of Fear and Anxiety

Fixed
Model Correlations
1
2
rA, rC, rE = 0
3
rA, rC, rE = 1
4
rA = 1
5
rA = 0
6
rC= 1
7
rC= 0
8
rE= 1
9
rE=0
10
rA=1 rC=0
11
rA=0 rC=1
12
rA=1 rC=1
13
rA=0 rC=0

EP
84
65
65
83
83
83
83
83
83
82
82
82
82

df/Δ
6499
3
3
1
1
1
1
1
1
2
2
2
2

Model Fit
-2LL
AIC
30065.0 17067.0
30377.6
17373.6
30109.6
17105.6
30047.6
17047.6
30049.7
17049.7
30038.0 17038.0
30044.4
17044.4
30097.5
17097.5
30087.4
17087.4
30045.4
17043.4
30052.3
17050.3
30038.6 17036.6
30096.9
17039.1

P
< .001
< .001
.999
.999
.999
.999
< .001
< .001
.999
.999
.999
< .001

Table 2 shows the fit statistics for all models tested. Model 1 is the full model with all
three latent correlations freely estimated. To test the significance of correlations
subsequent models constrained the correlations to 1 and 0. Table abbreviations: IPM
= Independent Pathway Models, rA= correlation between common latent genetic
factors, rC= correlation between common latent familial environmental factors, rE=
correlation between common latent unique environmental factors. Bold designates the
overall best fitting model.

Combined Independent Pathway Model
To examine which subscales were driving the correlations between latent factors
and explore a larger set of possible risk structures among fear and anxiety, we examined
an IPM with two sets of latent common ACE factors. To ensure model identification and
a unique solution, for each set of ACE common factors, we dropped one variable to
designate one set as the ‘anxiety’ set and the other as the ‘fear’ set. I.e., all SCARED
subscales load on the ‘anxiety’ ACE factors and all subscales except criticism from FSSCRSF do so as well, and the reverse with all FSSC-RSF and all SCARED except GAD loading
onto the ‘fear’ ACE set (as seen in Figure 3.5 in the C and E factor loading illustrations).
When testing a single common factor model (i.e., Ac1, but no Ac2), we allowed all subscales
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to load onto that single factor. In a test similar to fixing correlations to one in the
correlated common factors model, we successively dropped one of the common genetic
factors (Ac) then one each of the common environmental factors (Cc and Ec) to find the
most parsimonious model. While one of the two latent Ac factors could be eliminated
without a significant deterioration in fit, we were unable to remove any of the four
common environmental factors (i.e., keeping two each for Cc and Ec). The best fitting
was Model 3b in Table 3 with similar effects of age and sex as before.

Table 3.3 Model Fitting Results for Independent Pathway Model Including All
Symptom Clusters
Model Fit
Common
Specific
Model Factors
Factors EP df/ Δ
-2LL
AIC
P
1
A1A2C1C2E1E2
All ACE 102 6481
30146.6
17184.6
2
A1A2C1E1E2
All ACE 95
7
30051.4
17085.4
.999
3
A1C1C2E1E2
All ACE 95
7
30024.8 17048.8
.999
3a
A1C1C2E1E2
All CE
86
16
30040.1
17046.1
.032
3b
A1C1C2E1E2
All AE
86
16
30024.8 17030.8
.999
3c
A1C1C2E1E2
All E
77
25
30069.0
17057.0 < .001
4*
A1A2C1C2E1
All ACE 95
7
5
A1C1E1
All ACE 81
21
30105.4
17101.4
.999
6
C1E1
All ACE 72
30
30196.9 17202.9
.014
7
A1E1
All ACE 72
30
30170.8
17148.8
.762
8
A1C1
All ACE 72
30
30381.5
17359.5 < .001
9
All ACE 54
48
31999.8
18941.8 < .001
Table 3 shows the fit statistics for all models tested. Common Factors are the ACE latent
factors shared between all observed variables. Specific Factors are the nine sets of ACE latent
factors that each only load onto one observed variable, respectively. Specific factors were
tested by dropping a class at a time (e.g., all specific A latent factors dropped at same time).
Bold designates the overall best fitting model.
* Model 4 was unable to converge to a final solution
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The proportion of variance in liability accounted for by each source of variance is
listed in Table 4. Figure 3.5 illustrates the larger role of shared genetic influences on the
anxiety subscales, with limited influence of familial environment common to all subscales
and the largest proportion of unique environmental influences originating from subscale
specific factors. This partitioning is reflected in Table 4 where the total genetic influences
across shared and specific components account for 15-40% of the variance, whereas the
total variance accounted for by common and specific familial environment is markedly
lower (0-17%); the remainder was accounted for by some common but predominantly
specific unique environment (47-74%).

Table 3.4 Proportion of Variance in Liability to Anxiety and Fear Symptom Clusters
from Common and Specific Genetic and Environmental Risk Factors*
Familial
Unique
Genetic Factors
Environmental Factors Environmental Factors
Symptom
Cluster
Ac
As
Total Cc1 Cc2
Total
Ec1 Ec2 Es Total
PAN
.28
.12
.40
.03 .02
.05
.16 .00 .39
.55
GAD
.50
.03
.53
.00
.00
.12
.35
.47
SEP
.21
.12
.33
.02 .10
.12
.21 .04 .30
.55
SOC
.14
.26
.40
.02 .00
.02
.18 .02 .38
.58
CRIT
.37
.00
.37
.00
.00
.19 .44
.63
UNKN
.14
.00
.14
.02 .15
.17
.04 .27 .38
.69
ANML
.03
.18
.21
.06 .01
.07
.00 .18 .54
.72
DEATH
.14
.02
.16
.10 .00
.10
.00 .15 .59
.74
MED
.15
.04
.19
.15 .00
.15
.00 .26 .30
.66
Table 4. Panic disorder (PAN), generalized anxiety disorder (GAD), social phobia (SOC) and
separation anxiety (SEP), fear of failure and criticism (CRIT), fear of the unknown (UNKN), fear
of animals (ANML), fear of danger and death (DEATH), and medical fears (MED), Ac (Common
A factor), As (Specific A factor), Cc1 (First Common C factor) Cc2 (Second Common C factor), Ec1
(First Common E factor), Ec2 (Second Common E factor) Es (Specific E factor). Bolded columns
designate proportion of total variance accounted for by the combined common and specific
etiological sources of variance for each subscale.
*Best-fitting IPM model 3b from Table 3
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Figure 3.5 Best-Fitting Model for Fear and Anxiety Symptom Clusters
The model contains one common additive genetic factor (Ac1), two common
familial environmental factors (Cc1 and Cc2), and two common unique
environmental factors (Ec1 and Ec2). Only disorder specific additive genetic and
unique environmental factors were found to be significant and retained in the
final model. The darker lines indicate a stronger influence of the latent factor on
the observed variable. Lighter lines indicate a standardized path estimate less
than 0.10. Table 3 provides the proportion of variance accounted for by each of
these pathways.
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Discussion
We used multivariate SEM to examine the structure of genetic and environmental
risk factors that underlie the associations between fear and anxiety symptoms in a
juvenile twin sample.

We first separately examined each scale’s genetic and

environmental factors. Fear and anxiety each respectively displayed an overall similar
etiologic covariance structure that included moderate influences of genetic plus familial
and unique environmental factors common to all clusters (Figure 3.5). The remaining
influences were due to outcome-specific genetic and unique environmental effects. Prior
childhood studies have primarily focused on the etiology of particular fears119 and their
longitudinal changes over development124 or the etiology shared between fears or
phobias.126 Whether measuring diagnoses or symptom counts, extant studies reported
moderate genetic influences that were partially shared with other fears or phobias plus a
predominance of unique environmental influences. Our findings of significant fearspecific genetic and unique environmental effects, but little to no familial environmental
influences,

replicate

those

of

prior

studies

examining

these

domains

independently.125,126,233,234
Within AD symptom domains, a latent genetic factor Ac accounted for a modest
proportion of variance shared by all anxiety subscales except SOC. This is generally
consistent with the findings of Ogliari and colleagues.235 Differences between these two
studies are largely accounted for by our finding of an additional common familial factor
Cc, with modest influence on the covariance of subfactors that the other study did not
include in their final models. Overall, our findings of significant moderate genetic and
unique environmental influences are similar to previous independent studies of SOC,
SEP, and PAN in children.125,147,233
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Considering previous twin research that examined fear and anxiety separately in
children, our study provides novel insights into the potential etiological underpinnings
responsible for the high comorbidity and relatively parallel developmental sequence
observed between phobic fear and anxiety domains in youth. The correlated common
factors model yielded a structure consistent with very highly correlated common A and C
factors plus moderately correlated common E factors across symptom domains. The
combined IPM, with its greater flexibility in determining overall risk structure compared
to the correlated common factors model, then allowed a more detailed representation of
the covariance structure to emerge.
Within the combined IPM (Figure 3.5), risk across domains was variably
influenced by a single genetic factor (Ac) in addition to domain-specific familial
environment (Cc1 and Cc2), plus those unique to each individual (Ec1 and Ec2). The
proportion of variance accounted for by Ac is lower for fear symptoms (3-37%) than for
anxiety symptoms (14-50%). Only Ac accounts for greater than 30% of the variance for
any of the clusters affecting both fear of criticism and GAD, the most genetically
influenced of each domain (37% and 50% heritability, respectively).
While our best fitting model included multiple C and E factors, they only partially
distinguished between fear and anxiety clusters. Familial environment was not strongly
influential, and the pattern that emerged was not simply fear versus anxiety. As Figure
3.5 shows, C1 has a modest degree of cross-loading on anxiety symptoms and fear of death
and medical fears, although the influence on anxiety symptoms is minimal. Only SEP and
fear of the unknown load onto C2 with the remaining items receiving little to no influence.
This suggests an underlying relationship between responses to seemingly distinct threats
such as separation anxiety and fear of the unknown. However, both tap into related
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constructs of basic survival threat: the former due to separation from a source of safety
(caregiver) and the latter of facing unknown situations that nonspecifically threaten basic
survival without a caregiver’s protection. Notably, familial environment plays little role
in the comorbidities of internalizing disorders in adults.236
The only common factors to show an arguable distinction between the domains
were the unique environmental influences. Figure 3.5 shows all the anxiety symptoms
clustering together on Ec1 and all the fear symptoms on Ec2 with minimal cross loadings
from the other domain (represented by dashed lines in the figure). Since fear and anxiety
are differential responses to acute versus potential threat, their overall environmental
influences are likely to separately cluster. Fear is a more primitive, instinctive defensive
reaction primarily involving the amygdala and its recruitment of other subcortical regions
that develop early, while anxiety requires more complex responses dependent upon
cortical involvement which reaches maturity later than subcortical regions.237 In the
context of brain development these environmental influences may be more a reflection of
a child’s current ability to respond to a fear cue, whereas anxiety would require brain
regions that are not yet developed, thus a potentially biologically mediated process
appears as separate environmental influences. Furthermore, given that normative fears
are variably expressed within certain developmental windows (fear of strangers,
separation, the dark, animals, etc.), it is more likely for their environmental influences to
cluster according to exposures by age that make them more highly correlated with each
other than with environmental influences on anxiety symptoms.

That is, while

predisposing genetic influences of fear and anxiety largely overlap, their environmental
influences may be differentially moderated by age and neurodevelopmental stage.
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Our results further suggest that the etiological structures of fear and anxiety in
children are not as clearly differentiated as in adults. Prior adult twin studies report
substantial continuity of etiological influences among fears and their corresponding
phobias.121 Furthermore, both adult phenotypic238 and twin149 studies find correlated but
partially distinct structural relationships between phobias and other anxiety disorders.
Thus, while our finding of moderate levels of genetic influences common to all symptom
clusters is not unexpected, the degree of sharing seen here is notable. This reflects, and
likely helps explain, clinical observations in which children are substantially more likely
to have a complex, changing pattern of syndromes compared to adults.6,141,151,152
The results of this analysis should be interpreted within the context of several
limitations. While we were able to control for fixed effects of age and sex in the analyses,
this sample does not possess sufficient power to examine their detailed influences on the
latent genetic and environmental factors.239 However, previous studies have indicated
conflicting results regarding age and sex having a moderating effect on the variance of
fear and anxiety measures124,146,147; thus, we covaried for them at the means level to
minimize these biases.

Second, although it might limit generalizability to clinical

samples, a dimensional approach that reflects symptom measures increases the statistical
power to detect the influences of etiologic significance over use of categorical diagnoses.
Generalizability is also limited due to the exclusive use of Caucasian twin pairs driven by
the aim to minimize genetic heterogeneity introduced when sampling from multiple
ethnicities. Most prior twin studies were also conducted in Caucasian twins, maximizing
our comparability with them.
The findings of this analysis have implications for investigating the risk
mechanisms underlying fear and anxiety symptoms in childhood and beyond. From a
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trans-diagnostic perspective, these findings help explain and potentially validate the high
rates of comorbidity among internalizing disorders in children. Longitudinal research in
developmental psychopathology would benefit from incorporating both threat response
domains, given their close links in childhood. Studies in adults show a clearer distinction
between the two domains and their sources of covariation, while their expression in
children is more diffuse and malleable. From an etiological perspective this could be due
to the greater degree of shared genetic influences expressed during child development
coupled with developmentally specific environmental influences that help disentangle
fear and anxiety. A longitudinal study extending into late adolescence would further
inform the temporal unfolding of fear and anxiety risk factors as they merge into those
seen in adulthood.
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Chapter 4: Shared Etiology of Fear and Anxiety with Brain Morphometry
As discussed more thoroughly in chapters 1 and 3, fear and anxiety are adaptive
responses to threat; with fear being focused on more imminent danger that is linked to a
drive to survive, whereas anxiety is primarily focused on potential or long-term threats.237
Both threat responses have their basis in deep-seated motivations of continued survival.
However, misplaced, excessive, and unwarranted fear and anxiety can be maladaptive,
and clinically recognized as phobias and panic or generalized anxiety disorder (GAD).
This chapter considers the neurobiology of these fundamental threat responses and their
potential shared etiologies with fear-network related brain regions.
Many animal model research studies have focused on Pavlovian fear conditioning
and extinction as testable, although simplistic, processes relevant to anxiety-related
disorders such as phobias, and posttraumatic stress disorder. This translational model
has provided insights into the importance of the amygdala, hippocampus, anterior
cingulate cortex (ACC), and areas of the prefrontal cortex (PFC) in fear conditioning and
extinction.240 In humans, activation of these areas is also associated with tasks directly
investigating

fear

conditioning/extinction.10

Additionally,

differences

in

morphometry132,133 and functional activation18,23,128–131 of these areas have been
associated with phobias and other anxiety disorders, primarily in adults. The current
neurocircuitry-based understanding of many anxiety disorders such as GAD, panic, and
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posttraumatic stress disorder largely concerns over-activation and recruitment of the
‘fear network’ including the amygdala, hippocampus, and some brainstem structures,
with more recruitment of cortical areas such as the ACC, and ventromedial PFC (vmPFC),
compared to activation patterns of phobias. The latter two areas are associated with
anxiety disorders more focused on worry and other cognitive processes such as
generalized anxiety and social anxiety. Within the functional neuroimaging literature
there appears to be a general consensus that amygdala activation is exaggerated in
response to a variety of disorder-specific stimuli across many anxiety disorders such as
panic disorder156,157, social phobia13–16, generalized anxiety22,158,159, and posttraumatic
stress disorder.11,12
Published studies on structural brain differences between anxiety patients and
controls in adults are limited, and those of children more so. The latter are limited both
in number of studies and sample sizes, with most studies having 50 or fewer participants.
In three studies smaller hippocampal volumes were associated with childhood anxiety
disorders241 or symptoms242,243, whereas others found no significant differences.155,244–246
There are similarly conflicting findings for associations with amygdala volume. Some
studies report larger155,247 volumes associated with pediatric anxiety disorders, others
smaller241,245,248, and yet others finding no significant association.244,246 When
investigating areas of the prefrontal cortex, four studies reported smaller cortical
thicknesses (vmPFC/medial orbitofrontal cortex [mOFC]) among children with anxiety
disorders243,246–248, while another study found greater vmPFC thickness associated with
generalized anxiety.249 While these areas were originally identified for their involvement
in fear conditioning and emotional regulation, structural neuroimaging studies have had
limited success in finding associations between structural differences (i.e. thinner cortical
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thickness, or smaller volumes) in these regions and childhood anxiety disorders. Two of
the more recent studies used continuous measures of anxiety symptom severity with
varying degrees of success242,243, but most of the neuroimaging literature continues to use
case/control analytic approaches.
The aim of the present chapter is to test for an endophenotypic relationship
between brain regions of interest (ROIs) previously implicated in fear processing and
anxiety. This is accomplished by examining whether the ROIs are significantly associated
with a genetic factor score indexing fear and anxiety measures in this sample. While a
whole brain voxel-wise approach would be ideal, this chapter uses pilot imaging data from
a child anxiety study. In order to maximize its statistical power and limit the number of
statistical tests, a small number of preselected brain regions were analyzed. As such this
chapter focuses on the hippocampus, amygdala, ACC, lOFC, and mOFC of the left and
right hemispheres. The prefrontal region of the brain is divided into many sub-regions,
and depending on the brain atlas used in analyses, the same location in two studies can
be labeled as different areas. For these analyses the lateral and medial OFC labels refer
to the PFC and vmPFC of previous studies. Based on the previous literature and that two
of the larger loadings on the genetic factor score were for anxiety subscales, it is
hypothesized that this genetic factor score will be associated with an increase in
hippocampal and amygdalar volumes and a decrease in OFC and ACC sub-region cortical
thicknesses. The literature is ambiguous regarding direction of effect for some regions,
so these hypotheses were chosen based on representative prior studies that had measures
similar to this study.
In contrast to the prior studies that focused on anxiety case-control differences,
this chapter use a dimensional genetic factor score phenotype based on the best-fitting
74

model from chapter 3 that indexes fear and anxiety outcomes. It is hypothesized that this
score is more proximal to the biological processes related to fear and anxiety measures.
Additionally, since the genetic factor score indexes a latent liability to both fear and
anxiety measures, an exploratory aim seeks to investigate whether associations found
between ROI volumes and the genetic factor score are driven by a specific scale. This final
exploratory aim is designed to replicate a previous study243 that used anxiety symptom
sum scores to predict hippocampal volumes.

Methods
Participants
The twins included in these analyses are a subset from the Virginia Commonwealth
University Juvenile Anxiety Study (VCU-JAS). VCU-JAS enrolled twins aged 9-14 across
two sites (VCU and the National Institute of Mental Health; NIMH) to participate in a
study of internalizing phenotypes. Only Caucasian twins were recruited to minimize
heterogeneity within the sample for the genetic aims of the overall study.

The

Institutional Review Boards at VCU and NIMH approved this study, and parents of all
participants provided informed consent before participating.

Self-report and

neuroimaging data came from 105 youths (N=20 monozygotic (MZ) twin pairs, N= 24
dizygotic (DZ) twin pairs, and 17 singletons) aged 9-14 years old consisting of 60 female
and 45 male participants. These participants were recruited post-hoc from those who
participated in the larger VCU-JAS sample through an additional funding protocol.
Zygosity was determined using parental responses to standard questions about physical
appearance of the twins or DNA testing as described in detail elsewhere.227 For safety,
children were excluded from the imaging protocol if they had metal braces or other metal
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objects present in the body as an additional exclusionary criteria beyond those of the
primary study. The only other exclusion criterion was the participant’s general tendency
to be fidgety during the VCU-JAS assessments, since motion within the scanner disrupts
imaging signals.

Measures
Fear
The shortened 25-item form of the Fear Survey Schedule for Children Revised230
(FSSC-RSF) was used for the analyses in this chapter. The short form has a 5-factor
structure similar to the full scale: fear of failure and criticism, fear of the unknown, fear
of animals, fear of danger and death, and medical fears. Further details on this measure
can be found in chapter 3. For consistency with prior studies, a single sum score was
calculated for this measure and used as a general index of overall fearfulness with a mean
of 46.70 (SD = 26.14, and skew = 0.65).

Anxiety
The 41-item version of the Screen for Child Anxiety-Related Emotional
Disorders143 (SCARED) was used. This scale contains five subscales: panic (PAN),
generalized anxiety (GAD), separation anxiety (SEP), social anxiety (SOC), and School
Avoidance. Since School Avoidance is not related to a specific DSM-IV disorder, it is not
use in these analyses. Chapter 3 contains a more detail introduction to this scale. A single
sum score was calculated from the four DSM-related subscales and used as a general
index of overall anxiousness with a mean of 20.06 (SD = 10.78, and skew = 0.49).
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MRI acquisition
Structural images were collected at two sites: Virginia Commonwealth University
(VCU); and the National Institute of Health (NIH). At VCU a Philips Ingenia 3.0T scanner
with a 32-channel head coil was used. Imaging protocol included 3D magnetizationprepared rapid gradient-echo (MPRAGE) T1-weighted volume optimized for maximum
gray/white matter contrast with the following parameters: flip angle=6°; FOV=24 cm;
slices=160; slice thickness=1mm; 240x240 matrix; repetition time [TR]= 8.1ms; echo
time [TE]= 3.7ms). At NIH a General Electric 3.0T scanner with an eight-channel head
coil was used. The imaging protocol included a 3D MPRAGE T1-weighted volume
optimized for maximum gray/white matter contrast with the following parameters: flip
angle=7°; FOV=25.6 cm; slices= 176; slice thickness=1mm; 256x256 matrix; TR= 7.7ms;
TE= 3.4ms.

MRI Processing
Processing of images was performed using standard, automated procedures
available in the Freesurfer image analysis software suite, which is freely available for
download and fully documented (Version 6.0, http://surfer.nmr.mgh.harvard.edu/).
Processing consisted of motion correction187, correction of distortion due to gradient
nonlinearity and B1 field inhomogeneity, image intensity normalization188, removal of
non-brain tissue using a hybrid watershed/surface deformation procedure189, and
automated Talairach transformation. FreeSurfer software package routines190,191 were
used to define gray matter, white matter, segmentation of subcortical structures, and
cerebral spinal fluid segmentation. After cortical models were created, the DesikanKilliany250 probabilistic atlas was used to assign neuroanatomical labels to each
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voxel251,252 followed by subcortical volume and cortical thicknesses calculation using this
parcellation.

The procedures used for cortical thickness measurement have been

validated against histological analysis192 and manual measurements193,194. The protocols
used to obtain cortical thickness and subcortical volumes measurements have been used
in previous child psychiatric research243,249,253–256.

Cortical and Subcortical Measures
Prior to all analyses all ROIs were regressed onto age, sex, scan site, and
intracranial volume to account for the fixed effects of these covariates. ROIs examined in
this chapter include hippocampal volume, amygdala volume, rostral anterior cingulate
cortex (rACC) mean thickness, caudal anterior cingulate cortex (cACC) mean thickness,
lateral orbitofrontal cortex (lOFC) mean thickness, and the medial orbitofrontal cortex
(mOFC) mean thickness separately in both the left and right hemispheres of the brain, for
a total of 12 ROIs examined in these analyses. Figures 4.1 and 4.2 illustrate these areas
in the left hemisphere.

b

a

Figure 4.1 Divisions of the left orbitofrontal and anterior cingulate cortices
Panel a shows a sagittal cross section and b shows an inferior view of the left
hemisphere. Medial orbitofrontal cortex (OFC) is illustrated in dark blue, lateral
OFC in light blue. Caudal anterior cingulate cortex (ACC) is in light green and
rostral ACC is in dark green.
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a

b

c

Figure 4.2 Bilateral Structures of the Hippocampus and Amygdala
Panel a shows a sagittal view of the hippocampus (light blue) and amygdala (yellow), b
shows a coronal view and c shows a 3-dimensional bilateral reconstruction of the structures
with a sagittal cut of the left hemisphere to provide relative spatial context.

Statistical Analyses
Factor Scores
Genetic factor scores were created in OpenMx based on the final best-fitting twin
model from chapter 3. This twin model included a single common genetic factor for the
fear and anxiety measures described above. This factor score was created using a
regression predictor. In this approach the estimated parameters from a factor analysis
are used to define linear combinations of observed variables, which then generate the
factor scores. Specifically, the Thomson-Thurstone regression method257–259 was used,
which defines the factor score as the product of the factor loading matrix, the inverse of
the data covariance matrix, and a vector containing the data.

Factor scores were

calculated for the entire sample using the unstandardized factor loadings.
Mixed Effect Linear Regression
The random effects within a mixed effect linear regression were used to adjust for
possible effects of correlated observations in the twin data. In each regression, family ID
and zygosity denoted family membership and whether the pair was monozygotic or
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dizygotic, respectively, were entered as random effects. The umx() package was used to
obtain 95% confidence intervals for all standardized beta estimates.260

Results
Associations between genetic factor scores and 12 ROIs implicated in fear and
anxiety in adults were examined. Specifically, the genetic factor scores were used to
predict volumes of sub-cortical ROIs and mean thickness of cortical ROIs. A false
discovery rate (FDR) was used to account for testing of the 12 ROIs.261 Although none of
the results remained significant after multiple testing corrections, there were two regions
with unadjusted p < 0.05, the left and right hippocampi (Table 4.1). As a final exploratory
aim, the association between fear and anxiety total scale sum scores and the left and right
hippocampal volumes were examined, but no significant associations prior to FDR
correction were found (Tables 4.2 and 4.3, respectively).
Table 4.1 Genetic Factor Score predicting ROIs Measures in Separate Analyses
Region of Interest
β [95% CI]
t value
p
FDR p
L Hippocampus
76.86 [9.84, 143.88]
2.32
.026
.312
R Hippocampus
83.41 [6.92, 159.91]
2.20
.033
.396
L Amygdala
-21.7 [-61.13, 17.73]
-1.11
.273
.999
R Amygdala
-1.16 [-46.67, 44.34]
-0.05
.959
.999
L rACC
-0.03 [-0.1, 0.04]
-0.88
.382
.999
R rACC
0.00 [-0.07, 0.07]
-0.13
.900
.999
L cACC
-0.04 [-0.1, 0.02]
-1.41
.165
.999
R cACC
-0.02 [-0.07, 0.04]
-0.59
.560
.999
L lOFC
0.02 [-0.02, 0.06]
0.95
.346
.999
R lOFC
0.02 [-0.02, 0.06]
1.06
.296
.999
L mOFC
0.01 [-0.04, 0.05]
0.26
.794
.999
R mOFC
0.00 [-0.05, 0.04]
-0.21
.832
.999
β = standardized beta estimates, 95% CI = 95% confidence interval, FDR p= false discovery rate
adjusted p value, L = left, R = right, rACC = rostral anterior cingulate cortex, cACC = caudal
anterior cingulate cortex, lOFC = lateral orbitofrontal cortex, mOFC = medial orbitofrontal cortex.
Using data from VCU-JAS mixed effect linear regressions were performed to predict subcortical
volumes and cortical thicknesses based on genetic factor scores that index latent liability to fear
and anxiety within the sample
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Table 4.2 Continuous Measure of Fear Symptoms Predicting Hippocampal Volumes
Variables
(95% CI)
t value
p value
L hippocampus
1.71 [-0.26, 3.69]
1.75
.087
R hippocampus
2.09 [-0.31, 4.48]
1.76
.086
β = standardized beta estimates, 95% CI = 95% confidence interval, L = left, R =
right. Using data from VCU-JAS mixed effect linear regressions were performed
to predict hippocampal volumes based on fear symptom sum scores

Table 4.3 Continuous Measure Anxiety Symptoms Predicting Hippocampal Volumes
Variables
(95% CI)
t value
p value
L hippocampus
1.97 [-2.68, 6.62]
0.86
.396
R hippocampus
4.48 [-0.81, 9.77]
1.71
.095
β = standardized beta estimates, 95% CI = 95% confidence interval, L = left, R =
right. Using data from VCU-JAS mixed effect linear regressions were performed
to predict left and right hippocampal volumes based on anxiety symptom sum
scores

Discussion
Mixed effect linear regressions were used to examine whether specific ROIs were
associated with a genetic factor score indexing fear and anxiety within this child sample.
Prior to multiple-testing correction using FDR, the left and right hippocampal volumes
were significantly associated with greater genetic liability towards fear and anxiety. After
FDR correction no significant associations were found between the ROIs and a genetic
factor score indexing fear and anxiety.

Simpler individual-based fear and anxiety

measures were less informative.
Larger mean hippocampal volume has been previously found in adults with
anxiety262. However several child241–243 and adult134,135 anxiety studies have found either
decreases in hippocampal volumes, or no differences at all in child155,244–246 or adult263–
265

samples. Although most prior studies have implemented an anxiety disorder cases

versus healthy controls study design, two previous studies also examined anxiety
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symptom severity as a continuous measure associated with hippocampal volume242,243.
The first study by Koolschijn242 and colleagues examined the association between
hippocampal and amygdalar volumes with an internalizing disorder score derived from
the child behavior check list266.

They found lower left hippocampal volume was

significantly associated with higher internalizing symptom scores. In a similar approach
Gold and colleagues243 found higher SCARED total scale sum scores were significantly
associated with smaller right hippocampal volumes. Both studies are relatively large for
a child imaging study, and the Gold study using the SCARED is roughly the same size as
the current study (N = 108 and N = 105, respectively) with approximately the same
uncorrected p-values (0.02, and 0.03, respectively), although more regions were
examined in this study and none of the findings survived multiple-testing correction.
Since these analyses were focused on the genetic score which incorporates the SCARED
and FSSC-RSF scales and the potential associations found were in the opposite direction
of previous work, the next step was to specifically test whether hippocampal volumes were
associated with SCARED and FSSC-RSF total scale scores. In these follow-up analyses
no significant results were found that corroborated or contradicted the findings of Gold
et al.
There are several potential reasons for these null results. First, the morphometric
differences observed in adult and child anxiety disorder patients versus healthy controls
could be the result of neuroprocesses related to the specific disorders, and thus there may
not be a predisposing difference that is detectible prior to the onset of a clinically
significant symptom threshold. This seems unlikely as a justification applicable to all
anxiety disorders, however for some disorders these morphometric differences tend to
disappear with successful treatment such as with phobias.18,129,136 Second, this sample is
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still early in their onset trajectories for some of the ADs, with panic, generalized anxiety,
and posttraumatic stress (the last of which is not examined in this juvenile sample but is
of interest to this dissertation at large) having substantially later age of onset compared
to the other disorders such as specific phobias, separation anxiety, and social phobias.267
Given that panic and generalized anxiety with later onset ages were two of the largest
loadings on the latent genetic factor from chapter 3 it is possible that the genetic factor
score captured in these data does not fully account for the genetic variance expressed
across both developmental and disease trajectories and, as such, limits the ability to
detect significant associations. Lastly, these ROIs were originally selected as they are
frequently examined within adult anxiety functional neuroimaging research. However,
these ROIs are not consistently implicated in the more limited number of structural
studies of child anxiety disorders. Most adult and child studies are also limited by small
sample sizes, which further reduces their statistical power to detect significant results,
especially when examining all brain regions rather than a pre-specified list. Future
imaging studies with larger sample sizes are needed to fully address these research
questions in a more comprehensive manner than the extant literature offers.

The

Adolescent Brain Cognitive Development study (ABCD study) is in the process of
recruiting 11,500 9-10 year olds, including 800 twin pairs and will hopefully provide a
sample size large enough to examine structural differences associated with fear and
anxiety symptoms with adequate statistical power. The enhancing neuroimaging genetics
through meta analyses (ENIMGA) consortium may also be better suited to obtain and
properly harmonize the largest collection of psychiatric focused neuroimaging samples.
ENIGMA has already identified genetic loci associated with brain morphometry268 and
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has several working groups currently developing projects across a variety of phenotypes
including an anxiety focused working group (ENIGMA-ANX).
These findings, or rather the lack thereof, should be interpreted in the context of
several key limitations. First, the exclusive use of Caucasian twins pairs to minimize the
heterogeneity introduced with multiple ethnicities limits the generalizability of these
results. Second, it is possible that the most anxious and fearful participants from the full
sample chose not to participate in this imaging portion due to the potentially stressful
nature of additional imaging protocols. In fact, a 2-sample t-test shows a significant
difference (p = 0.04) between the SCARED sum score means of this subsample (mean =
20.06) and the full sample (mean = 22.31) as well as significant differences (p = .007)
between the fear sum score mean of the subsample (mean = 46.70) and the full sample
(mean = 53.91). These differences may have artificially limited the upper bound of the
fear and anxiety measures compared to the full sample and reduced the information
available for the regression analyses by removing participants with the most extreme
scores, which could be contributing to the null results of this study. Lastly, these results
may not generalize to clinical samples, because the measures of fear and anxiety are
dimensional measures rather than being based on clinical diagnoses of anxiety disorders.
In principle, this approach using full distributions of quantitative traits vs. categorical cutoffs should have increased the power to detect associations between genetic liability to
fear/anxiety and ROIs. To conclude, it is still possible that ROIs differ between anxiety
diagnoses and healthy controls. A study with a larger sample size may find the differences
sought in this chapter.
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Chapter 5: Global Discussion

The broad aim of this dissertation was to identify whether differences in specific
fear-network related brain morphometries were endophenotypes for PTSD, fear, and
anxiety. This was addressed by examining the etiological relationships between brain
morphologies, PTSD in adults, and fear/anxiety in children. The primary gap in the
current understanding of brain morphometry endophenotypes is whether specific regions
of interest (ROIs) have a genetic relationship to disorders to which they are
phenotypically associated.

This dissertation focused on establishing these genetic

relationships through twin data modeling and related analyses. In the case of PTSD,
trauma is known to be associated with adverse outcomes such as a PTSD diagnosis, but it
has also been associated with morphometric differences in the brain between traumaexposed and healthy individuals. In order to examine the etiological relationship between
PTSD and ROIs trauma, exposure must also be taken into account. The knowledge gained
from these analyses will be particularly useful as the fields of neuroimaging and genetics
continue to integrate, and larger neuroimaging datasets become publicly available.
In chapter 2, biometrical SEM was used to examine the shared etiology of PTSD
and ROIs while accounting for trauma using a large population-based sample. It was
found that thinning of fear-network related cortical areas, specifically the right ACC, left
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lOFC, and left mOFC, were associated with increased PTSD symptom sum scores.
Univariate twin models suggest that both genetic and unique environmental influences,
but not familial environmental influences, contribute to the etiology of PTSD and brain
morphology. Examination of the overlapping etiology of PTSD and each of these three
ROIs found that they had overlapping unique environmental influences, but they did not
have overlapping genetic influences, as reflected by the wide confidence intervals that
cross zero. These results would suggest that while ROI differences may be useful as
potential biomarkers for PTSD, they currently do not meet the criteria for
endophenotypes based on these analyses.

To be considered an endophenotype a

biomarker must be proven to associate with the disorder, be heritable, and have a genetic
relationship to the disorder identified through either family, twin, or measured genotype
based analyses.4 Although they did not share genetic influences, PTSD and ROIs did
demonstrate overlapping environmental influences that may be worth further study. As
a final step, the etiological relationship between PTSD and ROIs was examined in the
context of moderation by combat exposure. It appears the phenotypic associations
between them is entirely accounted for by moderation of combat exposure due to the fact
that inclusion of the combat exposure moderator completely removed the previous
environmental correlations between PTSD and each ROI. However, the moderation
estimates were small, and the instability of some of the models suggests the sample is
underpowered to make any definitive conclusions on the role of trauma in the etiology of
PTSD and ROIs.
Despite the limited sample size of this study, the differences in morphometry of
fear-network related brain regions do not appear to meet criteria for endophenotypes of
PTSD at this time, as there was no genetic overlap found in this study. Further research
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is needed via larger twin samples or measured-genotype based analyses to replicate and
extend these findings. One study has already had success identifying overlapping genetic
risk for obsessive-compulsive disorder with genetic influences on subcortical brain
structures.269 Future analyses similar to this study are currently in progress with the
Enhancing NeuroImaging Genetics Through Meta Analyses (ENIGMA) consortium.
Examination of epigenetic changes associated with trauma exposure may provide a causal
link between trauma exposure and the differences observed in brain morphometry.
Previous work in epigenome-wide studies has implicated methylation changes on genes
involved in immunity270 and methylation age271 with PTSD. The methylation age was
also negatively associated with neural integrity of the corpus callosum and nominally
associated with lower neural integrity of the left rACC, providing further support of
epigenetic effects of PTSD affecting brain morphometry. Differences in gene expression
patterns between PTSD and trauma-exposed controls have been identified and primarily
aggregate in genes associated with cortisol response272 (which is known to be dyrsegulated
in PTSD) and immunity.270

Further research into shared measured genotype and

methylation is being pursued by the PTSD working group of the Psychiatric Genomics
Consortium. This working group is focused on pooling PTSD cases and trauma-exposed
controls across many studies with the aim of finding genetic loci, methylation sites, and
differences in gene expression associated with PTSD. Ultimately combining work from
ENIGMA and the PGC may provide a causal mechanism that explains the current
phenotypic associations of PTSD and its brain biomarkers.
Chapter 3 investigated the shared etiology of fear and anxiety in children. The
measures of fear and anxiety were found to have an overall similar etiologic covariance
structure that included moderate influences of genetic plus familial and unique
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environmental factors common to all subscales of fear or anxiety with the remaining
influences due to outcome-specific genetic and unique environmental effects. When
examined together, the final best-fitting model for chapter 3 showed a single genetic
factor was common to all subscales of fear and anxiety. Familial environment was not
strongly influential, with many subscales showing minimal to no influence from the
familial environment. The only common factor to demonstrate a degree of distinction
between fear and anxiety was the unique environmental factor. Overall, these findings
suggest that although predisposing genetic influences for fear and anxiety largely overlap,
their environmental influences may be the distinguishing wedge that separates the
presentation of fear and anxiety from each other in children.
The results of chapter 3 suggest the high comorbidity of anxiety disorders
(including phobias) seen in community samples may be due, in part, to these highly
shared genetic influences. While studies in adults show a clearer distinction between the
two domains and their sources of covariation, their expression in children appears to be
more diffuse and malleable. The pattern of ‘same genes but, different environments’
found in this chapter is also found in the relationship between two other comorbid
disorders, depression and generalized anxiety.273,274 Fears, anxiety, and depression are
all considered internalizing disorders so it is possible that this shared genetic influence
may be tapping into something larger than just fear and anxiety. The genetic influence in
this chapter might be indexing something much more global such as a predisposition for
internalizing negative behaviors. Examination of additional internalizing symptoms and
behaviors would provide further insight into the interplay of fear and anxiety in a broader
context. Future gene finding efforts involving pediatric samples may benefit from the
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inclusion of multiple anxiety disorders or from the allowance of comorbidity with other
anxiety disorders in case status individuals.
Finally, chapter 4 tested whether ROIs previously implicated in fear processing
and anxiety have a genetically-based relationship with fear/anxiety in children. To test
this hypothesis the results from chapter 3 were used to create a genetic factor score
indexing latent liability to fear/anxiety. This genetic score is thought to be more proximal
to the biological processes related to fear and anxiety measures and may provide a
stronger link between self-report measures of fear and anxiety with ROIs. To test this
hypothesis, genetic factor scores indexing an individual’s latent liability to fear/anxiety
were incorporated into a mixed effect regression to predict ROI measures. After multipletesting correction no significant associations were found between the ROIs and the
genetic factor score, and simpler individual-based fear and anxiety measures were less
informative. There are two main potential reasons for these null results, including: 1)
morphometric differences may be due to disease related neuroprocesses and as such are
not detectible prior to the onset of a clinically significant symptom threshold; and 2) these
participants might be too early in their onset trajectories for a genetic factor score to fully
account for genetic variance expressed across developmental and disease trajectories,
which limits the ability to detect significant associations. While the genetic factor score
was unable to conclusively identify endophenotypes, it did provide preliminary evidence
for a genetic relationship between fear/anxiety and ROIs. Consortia and larger studies
that integrate genetically informative methods and neuroimaging, such as ENIGMA and
ABCD, are better situated to address the sample size limitations seen in this chapter.
Future research from these groups may benefit from using several different approaches
to incorporate genetics into neuroimaging research, such as implementing a classic twin
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design, or using polygenic risk scores created from large genome-wide association studies
(GWAS) of psychiatric disorders. Given the increase in genome-wide significant signals
from anxiety and stress-related GWAS275–281, Mendelian randomization is also an option
to examine potential causal effects of specific loci. However, identification of SNPs
associated with brain morphology is still a bit further behind compared to the field of
psychiatric genetics.

Limitations
The findings of this dissertation must be interpreted within the context of several
limitations of these analyses. Although detailed more thoroughly in previous chapters,
some of these limitations do provide a framework for future research into the intersection
of psychopathology, genetics and neuroimaging.
A limitation for all phenotypic measures across both samples is that they were
assessed via self-report questionnaires. This presents limitations in a few different
manners. First, the measure of trauma is dependent on participant report of combat
experiences 30 years prior, which raises concerns of recall biases. Second, results from
this dissertation may not generalize to clinical samples, because the measures of fear,
anxiety, and PTSD are dimensional measures rather than being based on clinical
diagnoses of disorders. Although, in principle, this approach, using full distributions of
quantitative traits vs. categorical cut-offs, should increase the power to detect associations
between phenotypes. Next, for both the adult and child samples all MRI data were
obtained at two sites, which was partly accounted for in analyses by regressing out any
contributions related to site of scan. Additionally, for both samples each twin was
scanned at the same site as their co-twin, and there were equal mixes of MZ and DZ twin
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pairs scanned at each site. The adult twin sample contained only male middle-aged
participants, so the results may not be generalizable to women, younger populations, or
individuals with trauma exposures other than combat experience. While it was possible
to control for fixed effects of age and sex within the analyses of the child sample, this
sample does not possess sufficient power to examine their detailed influences on the
latent genetic and environmental factors.

Additionally, previous studies indicated

conflicting results regarding age and sex having a moderating effect on the variance of
fear and anxiety measures124,146,147, so they were covaried for at the means level to
minimize these biases. Generalizability with results from the child sample is also limited
due to the exclusive use of Caucasian twin pairs, which was driven by the aim to minimize
genetic heterogeneity introduced when sampling from multiple ethnicities.

Conclusions
This dissertation used a trans-diagnostic framework to examine the shared
etiology of PTSD, fear, anxiety, and fear-network related brain morphometries. There
were several novel findings regarding etiology of threat-related domains, and associated
brain morphometry. Analyses investigating brain morphometric differences as potential
endophenotypes for PTSD provided preliminary evidence that their association is largely
accounted for by environmental influences, specifically trauma exposure. However, the
small sample size caused model instabilities, which in turn limited the ability to make
definitive conclusions. Examining domains of fear and anxiety in children found a
substantial genetic overlap between the two. Lastly, incorporating a genetic factor score
derived from the results of the previous chapter on fear and anxiety provided preliminary
evidence for a genetic relationship between fear/anxiety and ROIs.
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Although this dissertation extensively examined brain morphology of fear-network
related regions, there are still many alternative imaging modalities available for
examining the association between brain morphometry/functioning and psychiatric
disorders, and these may provide further insight into potential psychiatric
endophenotypes. Further research is needed to identify endophenotypes across these
modalities with the ultimate goal of linking disorder outcomes to genetic, epigenetic, and
gene expression changes. This understanding of biological pathways and mechanisms
that result in psychiatric disorders could eventually help identify potential prevention or
treatment options.
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